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THE EFFECT OF VASOACTIVE INTESTINAL PEPTIDE ON CHLORIDE CONDUCTANCE IN
AIRWAY EPITHELIAL CELLS.
Shelagh A. Houghton (Sponsored by Marie E. Egan, M.D.). Department of Pediatrics, Yale University,
School of Medicine, New Haven, CT.
The aim of this study was to characterize the effect and describe the mechanism of action of
vasoactive intestinal peptide (VIP) on chloride conductance in tracheal epithelial cells.
Two established cell lines were examined using single channel inside-out excised patch clamping
technique: the IB3-1 line, a cell line from a cystic fibrosis (CF)-affected child, and the S9 line, obtained by
transfection of the IB3-1 line with wild-type cystic fibrosis transmembrane conductance regulator (CFTR).
All cells were pretreated with VIP (lpM) for ten minutes and then examined in both cell-attached and
excised patch mode. If channel rundown occurred in the excised mode, ATP (ImM) was added to the
bathing solution.
In the IB3-1 line, 69% (9/13) of patches demonstrated no channel activity. The remaining four
patches (31%) contained channels characterized by a large amplitude and activation only after depolarizing
voltages > +70mV.

Both attributes are consistent with outwardly rectifying chloride channel (ORCC)

activity. These channels displayed no rundown and were not affected by addition of ATP.
In the S9 cell line, 83% (10/12) of excised patches demonstrated channel activity consistent with
CFTR chloride channels.

Mean conductance was 10.4pS±0.39pS.

Channel activity ran down in 80%

(8/10) of these channels; 75% (3/4) of patches treated with ATP after rundown demonstrated restoration of
channel activity. In addition, 50% (5/10) of S9 patches with channels also demonstrated a larger channel
suggestive of ORCC.
This study strongly suggests that VIP increases chloride conductance by stimulation of CFTR
chloride channels in the apical membrane.
second messenger cAMP.

VIP may activate CFTR directly, or indirectly through the

The data supports potential therapies that would maximize or complement

cAMP-stimulated chloride current, particularly in patients with CF mutations productive of suboptimally
functioning CFTR.
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1. Introduction

1-1. Inflammation
Inflammation is fundamentally a protective response initiated against substances
or organisms that threaten the body’s homeostatic mechanisms.

The inflammatory

response begins when cellular injury occurs by a variety of insults, including microbes,
toxins and mechanical stress. It continues even when the offending agent is eliminated,
as the host attempts to repair necrotic tissue and remove cellular debris.

However, in

both normal and pathophysiology, the inflammatory response can extend beyond the
scope of constructive repair, and, in fact, cause tissue damage with exacerbation or
development of symptoms unrelated to the initial condition.
The basic sequence of events in the acute inflammatory response is similar against
many forms of injury. Immediately following tissue injury, major changes occur in blood
vessels supplying the violated area which permit both increased blood flow and
transmigration of leukocytes from the blood to the interstitium. Vessels become dilated
and increasingly permeable. This leads to slowing of the circulation as protein-rich fluid
flows into the interstitium, leaving predominantly red blood cells in vessels. With stasis,
leukocytes extravasate, first adhering to the endothelium and then squeezing through
junctions between endothelial cells into the interstitial space.

Having escaped the

confines of the vasculature, leukocytes move toward the site of injury by chemotaxis and,
having reached the appropriate site, are activated by distinct chemical and mechanical
signals.

The leukocytic response to membrane changes is manifest as release of
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lysosomal enzymes, oxygen metabolites, and products of arachidonic acid metabolism
(prostaglandins and leukotrienes).

These products are essential mediators of the

inflammatory response and form part of the amplification cascade following acute injury.
However, unlike cellular immunity, these defenses are non-specific and can paradoxically
cause direct endothelial damage and tissue injury.

When this response proceeds

unchecked, the inflammatory response itself engenders a milieu within the affected
system characterized by edema, poor perfusion, fibrosis, and creation of an environment
suitable for superimposed bacterial or fungal infection.
Signaling required for the necessary vasodilation, increased permeability, and
chemotaxis stems from one of many distinct inflammatory mediators, which may be
derived from damaged cells, plasma, mast cells, and nerve endings. Cells stimulated by
mechanical or chemical disruption are the source of arachidonic acid metabolites, the
prostaglandins and leukotrienes.

Activated plasma triggers four interrelated cascades:

the complement, kinin, fibrinogen, and coagulation systems.

Activated mast cells and

nerve endings of both the autonomic and non-adrenergic, non-cholinergic systems
produce neuropeptides, such as VIP, Substance P, and the tachykinins.

How these

inflammatory mediators modulate function specifically in the human respiratory tract is
important in understanding both the etiology and possible therapeutic options in lung
pathophysiology.

1-2. Physiologic Role of Inflammation in the Lung
In the respiratory system proper functioning of the inflammatory response
prevents chronic infection or colonization by pathogens and eradicates chemical or
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mechanical irritants. The epithelial layer lining the respiratory tract is an integral part of
the defense system. Humans rely on the mechanical barrier of the nasal mucosal layer,
immunologic systems in the conducting airways and alveoli, and the mucociliary ladder
(Welsh, 1988).
Airway secretions provide the essential conduit of the mucociliary clearance
ladder. The ladder serves mechanically to remove inhaled matter from the lung through a
combination of ciliary movement and fluid wash.

Cilia are immersed in a 6 pm-thick

layer of fluid, the aqueous sol or periciliary layer. Quantity and quality of the fluid layer
are controlled by electrolyte transport through the respiratory epithelium.

The mucus

layer, which is 5 to 10 pm thick, covers the periciliary layer, and traps foreign particulate
matter. Mucus is produced primarily by non-ciliated goblet cells and also, in the larger
conducting airways, by submucosal glands. Beating of the cilia in the periciliary fluid
establishes coordinated movement by which foreign matter trapped in the mucus layer is
transported toward the glottis (Welsh, 1988).
Inflammatory

mediators

promote

changes

in

mucus

production,

vascular

permeability, smooth muscle contractility, and fluid and ion movement that collectively
enhance both recruitment of opsonic and phagocytic elements into disrupted areas and
clearance of noxious material from the respiratory tract along the mucociliary ladder.
The normal response to infection or irritation consists of release of mediators that
stimulate increased secretions into the airway lumen to wash out irritants and supply
phagocytic elements. These secretions can be too voluminous, as in asthma, which leads
to airway plugging, or insufficient, as in cystic fibrosis, with consequent hyperviscosity

4

and sludging.

In either case, bacteria and airway irritants persist.

In addition, the

ongoing nidus of irritation prompts continuous inflow of host cellular elements (PMN’s,
lymphocytes, and macrophages) which, as described above, can cause direct damage.
The cellular mechanisms by which inflammatory mediators such as leukotrienes,
prostaglandins, VIP, Substance P, and the tackykinins increase airway secretions remain
unclear. Understanding the details of these pathways may ultimately provide therapeutic
options in the treatment of severe respiratory diseases.

1-3. Regulation of Airway Secretions
Both chloride secretion and sodium absorption influence the composition and
quantity of the fluid bathing the respiratory epithelium.

The relative contribution of

either of these functions is determined by the neurohormonal milieu and the anatomical
region of the airway (McCann and Welsh, 1990). An ability collectively to secrete fluid
depends on the structure of each epithelial cell lining a particular portion of the airway.
Cells are polarized, with an apical aspect lining the lumen, and a basolateral face lining
the interstitial space. Membrane at either end has properties specific to the region of the
respiratory system and reflects the physiological role of the cell. The isolation of certain
transporters or channels to the apical or the basolateral pole permits either net absorption
or net secretion. Epithelial cells lining the respiratory tract are joined along their apical
(lining the lumen) borders by tight junctions. The resulting wall of cells creates a semipermeable barrier:

ions, certain solutes, and water may move across the barrier, while

other molecules and charged particles may not pass.
solutes may move:

Two pathways exist by which

through the tight junctions and between cells, referred to as the
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paracellular pathway, or through channels or transporters in the apical membrane of the

cells themselves, also known as the cellular pathway (Welsh, 1988).
The balance between sodium absorption and chloride secretion from the apical
membrane of respiratory epithelium is the primary factor in determining the degree of
fluid production. Differences in the magnitude of chloride secretion and net luminal fluid
flow in various parts of the human airways depend on the prevalence of chloride channels
correlating with the functional demands of the cells in the region.
chloride secretion is otherwise the same (Figure 1).

The mechanism of

First, chloride enters cells in a

neutral cotransport with sodium and potassium along the basolateral membrane against
an electrochemical gradient (more intracellular than extracellular chloride). The nature of
this cotransporter may differ among cell types, but is likely to be either a Na /Cl
cotransporter or a Na7 K+/C1‘ cotransporter (McCann and Welsh, 1990).

Energy

necessary for this process is provided by coupling with sodium, which is moving down an
electrochemical gradient created by the Na+,Kf-ATPase also located in the basolateral
membrane.

The basolateral membrane has potassium channels, which permit passive

movement of potassium down the chemical gradient created by both the Na+,K7-ATPase
and the chloride transporter.

The potassium channels are important in maintaining

negative intracellular voltage (Welsh, 1988).
The second step in chloride secretion through the cellular pathway involves
specific chloride channels located in the apical membrane.

Several distinct chloride

channels have been identified in the apical membrane of both epithelial and nonepithelial
mammalian cells.

These channels, which include the cystic fibrosis transmembrane

conductance regulator (CFTR) chloride channel, an outwardly rectifying chloride channel
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Interstitium

Lumen

Key to Symbols

ATPase

Cotransporter

Ion Channel

Figure 1. Mechanism of chloride secretion by airway epithelial cells.
The
basolateral membrane contains a Na7Cl' or a Na7K7CT cotransporter, the Na+,Kf
ATPase, and a K+ channel. The cotransporter exploits the Na+ gradient generated by the
ATPase to accumulate chloride within the cell. Opening of a channel in the apical
membrane permits efflux of chloride down its electrochemical gradient. In a non-leaky
epithelium, K+ leaves the cell on the basolateral side to compensate for the charge lost by
the cell in the secretion of chloride.
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(ORCC), and a calcium-activated chloride channel, are responsible for the movement of
chloride from the serosal to the mucosal side of the cell. Fruitful functional studies have
utilized apical membrane, whole-cell, and single channel patch clamp techniques to
measure conductance and voltage variability.

Essential to distinguishing chloride

channels is examination of the individual functional profile.

Average chloride

conductance, current-voltage (I-V) relationship, voltage dependence, and reaction to
agonists or antagonists comprise a set of features apparently unique to each variety of
channel.

1-3.1. CFTR Chloride Channel
In the early 1980’s electrophysiologic studies of cystic fibrosis (CF) affected
sweat ducts (Quinton, 1986) and airways (Knowles et al., 1983) demonstrated that the
primary defect in CF was a decrease in chloride permeability in epithelial cells. In 1989,
the genetic mutation associated with CF was identified. The gene that is defective in CF
encodes for the cystic fibrosis transmembrane conductance regulator (CFTR) (Riordan et
ah, 1989)(Bear et ah, 1992).

Mutations in CFTR eliminate or reduce chloride

conductance from the apical membrane of predominantly epithelial cells and, clinically,
result in the phenotype characteristic of cystic fibrosis, the most common lethal genetic
disease in Caucasians. Unclear, however, was the issue of whether the physiologic defect
resided with an improperly functioning channel or with defective regulation of a normal
channel. Conjecture regarding the role of CFTR revolved around two primary options:
either CFTR was itself a chloride channel or CFTR was a regulator of chloride, and
perhaps other, ionic channels.
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Prior to identification of CFTR, excised, inside-out single channel patch studies
suggested a link between protein kinase A (PKA) and intracellular nucleotides, and
activation of chloride channels. While addition of the catalytic subunit of PKA and ATP
opened chloride channels in membranes from normal cells, similar manipulation of CFaffected cells failed to increase chloride movement.

This data supported early theories

that the CF defect presented a problem distal to the receptor or initiation of a second
messenger cascade, perhaps residing in a regulatory protein or the channel itself
(Schoumacher et al., 1987)(Greger et ah, 1988)(Li et ah, 1988). However, identification
of CFTR was necessary to complete the puzzle.
The structure of the protein predicted by the amino acid sequence consists of two
sets of six transmembrane domains, two nucleotide binding folds, and an intracellular
hydrophobic regulatory, or R, domain (Figure 2).

This structure resembles that of the

ATP binding cassette, or ABC, family of transporters, a group of proteins that mediate
selective movement of solutes across membranes (Higgins, 1995).

Among ABC

transporters are the P-glycoproteins, which transport verapamil and vincristine and confer
drug resistance in bacteria and cancer cells; the SUR receptor for sulphonylureas; and
the sterile 6 protein of yeast which transports the “a” mating factor (Higgins, 1995). All
ABC transporters share a common structure, with four fused or independent core
domains. Two membrane spanning domains straddle the core and serve as the pathway
through which solute crosses the membrane;

these transmembrane domains determine

the specificity of the channel by their particular amino acid sequence. Alteration of the
anion selectivity after mutation of four basic amino acids in the CFTR transmembrane
domain justified belief that CFTR itself is a chloride channel (Anderson et al., 1991b). In
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Cl

Figure 2. Cystic fibrosis transmembrane conductance regulator. The structure, as
predicted by the amino acid sequence, consists of two membrane-spanning domains (TM)
with six membrane spanning segments each, two nucleotide binding domains (NBD), and
an intracellular regulatory domain (R). The R domain contains multiple consensus
phosphorylation sites for priming of the channel by PKA and PKC (denoted by •).
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addition, two putative nucleotide-binding domains on the cytosolic surface provide
energy for solute movement via ATP hydrolysis in many ABC transporters (Hyde et al.,
1990)(Ames and Lecar, 1992)(Higgins, 1995).

The role of these domains in CFTR is

discussed below.
The CFTR chloride channel is singular among ABC transporters in that it is an
ion channel, not an active transporter. In addition to being a channel itself, CFTR also
regulates several other ion channels, including the outwardly rectifying chloride channel
(see discussion below);

sodium channels, with increased sodium absorption through

dysfunctional regulation by CFTR of the amiloride-sensitive sodium channel, ENaC
(Chinet et al., 1994); and calcium-activated chloride channels, which are up-regulated in
cystic fibrosis (Grubb et al., 1994). Consequent derangement of these other channels may
contribute to the pathophysiology of CF.
Also unique to CFTR among ABC transporters is the regulatory, “R” domain,
which contains multiple phosphorylation sites for cAMP-dependent protein kinase A
(PKA) and protein kinase C (PKC) (Riordan et al., 1989)(Rich et al., 1991). The current
working model for CFTR pictures the protein forming a chloride channel in which the
transmembrane domains form the pore and the R domain functions as a channel plug,
somewhat like a ball fitting into the pore.

Phosphorylation of the R domain by PKA

prepares the protein, either by effecting a conformational change or by creating an
electrostatic repulsion of the R domain away from the membrane, to be accessible to a
chloride ion (Cheng et al., 1991). When the R domain blockade is removed, binding of
ATP at the first NBD and subsequent hydrolysis permits channel opening. Binding and
hydrolysis of ATP at the second NBD allows channel closure. Dephosphorylation of the
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R domain by specific phosphatases results in actual closure of the channel (Tabcharani et
ah, 1991)(Berger et ah, 1993)(Hwang et ah, 1993)(Davis et ah, 1996).

Evidence to

support this current model will be discussed in subsequent sections.
As described, the CFTR channel is regulated by PKA

phosphorylation and

intracellular ATP. Agents that increase cAMP, such as B-adrenergic agonists, forskolin
(an

adenylate

cyclase

phosphodiesterase
initiating

the

activator),

inhibitor),

second

and

effectively

messenger

3-isobutyl- 1-methylxanthine
increase

cascade

apical

leading

chloride
to

(IBMX,

a

conductance by

activation

of

PKA.

Electrophysiological studies have confirmed the unique functional characteristics of this
channel.

At baseline, the CFTR channel exhibits little or no chloride conductance;

addition of cAMP results in a dramatic increase in chloride current (Anderson et ah,
1992).

The channel is not affected by intracellular calcium;

the response to cAMP

persists in cells which have been buffered with calcium chelators, such as EGTA. The
CFTR chloride channel is a linear, 8-10pS chloride channel located in the apical
membrane (Cliff et ah, 1992) and lacks time-dependent voltage effects (Anderson et ah,
1991c). The channel is further characterized as being selective for anions over cations,
and by having an anion selectivity preference of bromide>chloride>iodide>fluoride
(Anderson and Welsh, 1991).

Slight outward rectification seen with

high pipette

chloride concentration is most likely secondary to the pipette-to-cell chloride gradient,
and is not of physiologic consequence (Cliff et ah, 1992). Physiologically, it is classified
as non-rectifying (Overholt et ah, 1995).

This channel is inhibited by glibenclamide,

which was previously thought to be a specific K+ channel blocker (Rabe et ah, 1995).
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1-3.1.1. cAMP Dependence of CFTR

Studies using recombinant CFTR to transfect both CF-affected cells and normal
cells that do not ordinarily express CFTR have demonstrated the role of cAMP in channel
activation. Whole cell patch clamp studies using CF airway epithelia and a CF pancreatic
cell line (CFPAC-1) demonstrated an increase in chloride conductance after transfection
with CFTR (Anderson et al., 1991c) (Drumm and Collins, 1993). Additional studies in
which nonepithelial mammalian cells without endogenous CFTR were transfected with
recombinant CFTR demonstrated generation of chloride current activated by cAMP
agonists including forskolin, IBMX, and dccAMP (a membrane-permeable form of
cAMP).

Cell lines employed included NIF1/3T3 fibroblasts (Anderson et al., 1991b),

Chinese hamster oocytes (CFIO) (Anderson et al., 1991c), and HeLa cells (Anderson et
al., 1991c).

When these same cell lines were transfected with mutant CFTR vector

(AF508, deletion of phenylalanine at position 508, the most common mutation), no
increase in chloride conductance was observed upon stimulation. Moreover, when T84
cells, human colon carcinoma epithelial cells with high endogenous expression of CFTR,
were transfected with CFTR, cAMP-activated halide permeability was greater than that
observed with non-transfected cell lines.

This indicates that overexpression of CFTR

causes an increased anion permeability, and supports the suggestion that CFTR effects a
dose-related response in cAMP-mediated anion conductance (Anderson et al., 1991c).
Similar single channel studies have produced data with results supporting the whole cell
studies linking CFTR to a reversible cAMP-mediated increase in chloride current (Bear et
al., 1991)(Dalemans et al., 1991 )(Kartner et al., 1991)(Anderson et al., 1992).
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Cells

expressing

endogenous

CFTR

display

cAMP-activated

chloride

conductance with functional properties similar to those described in cells transfected with
known CFTR. In order for a chloride current to contribute to the net movement of fluid,
the current must originate in the apical membrane of the cell.

To analyze apical

membrane chloride movement specifically, normal cell lines were treated with nystatin,
which functionally eliminates the basolateral membrane, and then grown on permeable
supports. In this setup, normal airway and intestinal epithelium (T-84, Caco-2, and HT29) displayed an increase in apical membrane chloride conductance upon addition of
cAMP.

In contrast, epithelial cells cultured from CF-affected airways did not

demonstrate an increase in chloride conductance with addition of cAMP (Anderson and
Welsh, 1991).

Experiments utilizing the Caco-2 cell line transfected with a mutant

regulatory subunit of cAMP-dependent protein kinase have shown a decreased chloride
efflux in response to potent cAMP agonists, including forskolin, membrane permeable
analogs of cAMP, VIP, PGE2, and isoproterenol. These results indicate that cAMP and
PKA are essential components of secretogue-regulated chloride conductance (Krolczyk et
al., 1995).

The similarities between the functional characteristics of chloride channels

observed in these studies of the apical membrane of normal and CF-affected cells
compared with the properties of channels seen in CFTR-transfected cells is strong
evidence that the cAMP-regulated chloride channel observed in the apical membrane of
natural epithelium operates through CFTR.
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1-3.1.2. Role of the Regulatory Domain

Other studies have further elucidated the mechanism of action of PKA
phosphorylation and ATP binding and hydrolysis, creating a picture of the integrated
functioning of the R domain and nucleotide binding domains.

One model posits the R

domain as a structural inhibitor, which physically blocks the channel.

This theory is

supported by studies in which CFTR with a deleted R domain functions exactly as a wildtype CFTR chloride channel except that it is constitutively open (Rich et al., 1991). In
wild-type CFTR, one of four serine residues in the R domain must be phosphorylated for
channel activation (Cheng et al., 1991). Although data had suggested that simultaneous
mutation of all four serine residues was required to prevent cAMP-dependent channel
activation, recent studies demonstrate that mutant CFTR lacking all four serine residues
can still be phosphorylated to an active chloride channel, but that the open state
probability is reduced (Rich et al., 1993).

The implication that other regulatory sites

within the R domain exist is supported by experiments locating additional phosphorylated
serines in the R domain (Seibert et al., 1995).
CFTR chloride channels require PKA for initiation of channel activity and ATP
for channel opening. Structural characterization of the R domain suggests that initiation
of CFTR chloride channel activity by PKA phosphorylation involves conformational
changes in the R domain wrought by the additional negative charge of the phosphate
(Rich et al., 1993)(Dulhanty and Riordan, 1994).

This change exposes the pathway

through which ions traverse the membrane. Although CFTR requires PKA to prime the
channel, PKA is not required for continued channel activity.

The CFTR channel can

remain open, in the absence of specific phosphatases, if PKA is removed. However, the
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presence of specific phosphatases can result in dephosphorylation of the R domain and
subsequent rundown of channel activity, which is restorable by addition of the catalytic
subunit of PKA and ATP (Tabcharani et ah, 1991).

1-3.1.3. Role of the Nucleotide Binding Domains
Existence of the two nucleotide binding domains is a feature unique to CFTR
among ion channels, but characteristic of the ABC family of transporters. When NBD’s
exist in other proteins, they often serve to hydrolyze ATP as a source of energy for
substrate transport.

Understanding of CFTR as a chloride channel that passively

transports chloride down an electrochemical gradient implies that ATP is not directly
used as energy currency to move chloride. However, ATP and ATP derivatives do bind
to recombinant peptides corresponding to nucleotide binding domains in vitro (Thomas et
ah, 1991). Moreover, mutations in one or both of these domains, particularly in NBD1,
accounts for a disproportionate number of mutations responsible for CF, implying that
whatever reaction occurs there is required for normal function (Cutting et ah,
1990)(Kerem et ah, 1990). Thus, the question remains whether hydrolysis occurs after
binding, and, if so, whether it serves a regulatory or direct channel gating function.
Several lines of evidence bolster the argument that hydrolysis is an essential
component of CFTR function. Although the channel can remain open in the absence of
PKA., the channel closes if ATP is removed after PKA phosphorylation, manifest as
observed rundown of activity after channel excision. Resupply of ATP, as well as other
hydrolyzable nucleotide triphosphates (ATP>GTP>ITP=UTP>CTP;

8-azido-ATP), to

the cytosolic surface of CFTR results in reopening of the channel (Anderson et al.,
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1991a)(Travis et al., 1993).

Nonhydrolyzable ATP analogs, such as compounds with

modified polyphosphate moieties (ADP, AMP-PNP), and Mg2+-free ATP are not
effective in opening the channel. ATPyS , which is an analog of ATP with a slow rate of
hydrolysis, substitutes for ATP in PKA phosphorylation, but does not successfully open
the channel (Anderson et al., 1991a)(Nagel et al., 1992). In addition, the open probability
(P0) of the channel increases directly as a saturable function of ATP concentration
(Venglarik et al., 1994).
While ATP is required for continued channel activity, ADP inhibits ATPdependent CFTR channel gating. In the presence of ATP, increasing concentrations of
ADP progressively inhibit current in a pattern consistent with competitive inhibition.
Mutation of three sites in the second nucleotide binding domain (NBD2) abolishes this
inhibitory effect, suggesting that the inhibitory effect resides with NBD2 (Anderson and
Welsh, 1992).

Inability of ADP to open the channel (Anderson et al., 1991a) and

simultaneous competition with ATP for binding at the NBD, summarily prevents channel
opening when ADP is present (Schultz et al., 1995).

Understanding this relationship

between the ratio of ATP and ADP leads to an explanation of how the metabolic state of
the cell might determine certain cell activities. In this scheme, CFTR is able to sense the
cell’s energy level and modulate chloride secretion accordingly.
Interestingly, function of the two NBD’s is not equivalent.

Mutations in two

conserved regions thought to represent sites for ATP binding found in both NBD1 and
NBD2, the Walker A and Walker B consensus sequences, produce strikingly different
results.

Mutation of lysine of Walker A results in a decrease in sensitivity to channel
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activation, while the opposite is true of mutation of the same lysine in Walker A of NBD2
(Smit et al., 1993).

This recent work supports previous studies of NBD mutations

proposing two ATP binding sites with differential functions (Anderson and Welsh, 1992).
Inorganic phosphate analogs, including V04 and BeF3, inhibit enzymes that catalyze
phosphoryl transfer reactions (e.g. ATPases). When added to cell patches in which
channels have been opened by addition of ATP, the channels become stabilized, or
“locked,” in the open conformation (Baukrowitz et al., 1994). Furthermore, AMP-PNP,
which is a nonhydrolyzable analog that binds only at NBD2, could not open the channel,
but did prolong P0 of channels already activated by ATP (Hwang et al., 1994). This data
supports models in which hydrolysis at one or both NBD’s contributes an essential
component to channel gating.

In these schemes, the two NBDs appear to function

differently, with binding and hydrolysis of ATP at NBD1 effecting channel opening, and
similar action at NBD2 resulting in channel closure (Davis et al., 1996).
Despite this growing collection of data which seems to support the role of ATP
hydrolysis, controversy persists.

While the NBD’s can have a regulatory function via

nucleotide binding without hydrolysis (i.e. via ADP competitive inhibition), the question
remains whether a regulatory role exists that requires nucleotide hydrolysis. Studies of
epithelia in which the basolateral membrane was permeabilized with a-toxin produced
data supporting the ability of non-hydrolyzable ATP analogues to augment apical
chloride conductance.

In these experiments involving human sweat ducts (Bell and

Quinton, 1993) and T84 cells (Quinton and Reddy, 1992), nonhydrolyzable ATP
analogues activated previously phosphorylated CFTR channels.

This appears to
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contradict the single-channel studies described previously. Explanations abound for this
seeming incongruity. Research indicates that certain ATP analogues react with some, but
not all, ATPases (Moos et al., 1960). Thus, in order to discuss whether hydrolysis occurs
at an NBD, one must first prove that the ATP analogue in question is in fact interacting
with the protein. For example, AMP and non-hydrolyzable analogues (AMP-PCP, AMPPNP, AMP-PCP, ATPyS) have polyphosphate moieties significantly different from ATP,
and may simply not interact with the hydrolytic enzyme portion of CFTR, or may require
other conditions, such as a highly phosphorylated state, to bind adequately (Schultz et ah,
1995).

A second line of reasoning relies on differences in experimental conditions to

explain inconsistent outcomes.

For example, experiments conducted at 25°C in the

continued presence of PKA produced a P0 greater than that seen in experiments in which
AMP-PNP was added.

This indicates that the nonphysiologic temperature induces a

different kinetic state, independent of the addition of the nonhydrolyzable ATP analogue
(Schultz et ah, 1995).

1-3.1.4. Role of Other Kinases

The role of protein kinase C (PKC) in activation of the CFTR chloride channel is
less clearly defined.

Recent work has identified both calcium-dependent and calcium-

independent isoforms of PKC-activated CFTR chloride channels.

In the calcium-

independent model, PKC directly phosphorylates CFTR (Berger et ah, 1993). However,
conflicting studies report that while activation of PKC causes a modest increase in the
magnitude of CFTR chloride currents, it more significantly confers a marked reduction in
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stability of CFTR chloride currents in pancreatic duct cells (Winpenny et al., 1995).
Even when PKC functions in CFTR activation, it alone stimulates only approximately
10% of the current stimulated by PKA (Tabcharani et al., 1991)(Berger et al., 1993).

1-3.2. Outwardly Rectifying Chloride Channel
Prior to identification of CFTR, the chloride channel responsible for the CF defect
was thought to be an outwardly rectifying, 30-50 pS channel, called the outwardly
rectifying chloride channel (ORCC).

Like other chloride channels, the ORCC has

distinct functional and electrophysiologic properties that distinguish this channel.
channel has an ion selectivity sequence

The

of iodide>bromide>chloride, demonstrates

voltage dependence, and is sensitive to inhibition by 4,4’ diisothiocyanostilbene-2,2’
disulfonic acid (DIDS).

Thus, the biophysical properties differ completely from those

now known to describe the small conductance CFTR chloride channel (Table 1).
However, early research on the molecular basis for the CF defect described
aspects of ORCC functioning that appeared to coincide with expectations for the CF gene
product. Data indicated that the ORCC was activated by cAMP agonists in cells without
the CF defect (Frizzell et al., 1986; Berger and Welsh, 1991) and, inconsistently, by the
catalytic subunit of PKA and PKC (Li et al., 1988)(de Jonge et al., 1989)(Hwang et al.,
1989)(Jetten et al., 1989).

In contrast, activation of ORCC by cAMP and PKA was

defective in tissue from patients with CF (Chen et al., 1989)(Hwang et al., 1989)(Jetten et
al., 1989). Of note, even in CF-affected cells, the channel could be activated with trypsin,
strong depolarization, and excision at 37°C (Schoumacher et al., 1987)(Hwang et al.,
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Table 1
Properties of Apical Chloride Channels

Biophysical Properties

CFTR

ORCC

Conductance

8-10 pS

20-30 pS

I/V Curve

Linear

Outward rectifying

Inhibitors

DPC
Glibenclamide

DIDS

Activation

PKA
ATP
(intracellular)

Voltage
ATP
(extracellular)

Br > Cl > T

T > Br > Cl

Ion Selectivity

!

Definition of abbreviations:
CFTR =cystic fibrosis transmembrane conductance regulator;
ORCC=outwardly rectifying chloride channels;
I/V curve=current voltage relationship;
DPC=diphenylamine-2-carboxylic acid; DIDS=4,4’ diisothiocyanostilbene-2,2’ disulfonic acid;
ATP=adenosine triphosphate
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1989). Appearance of channel activity only under these conditions implied that ORCC
was present in CF patients, but improperly regulated, and that dysfunctional regulation of
this channel represented the primary defect in CF.

Subsequent identification and

expression of CFTR lead to research that illustrated singular properties of CFTR which
were different from those expected for ORCC.

Expression of CFTR cDNA in various

systems did not produce a channel with biophysical characteristics consistent with those
observed for ORCC (Bear et al., 1992). Furthermore, the presence of currents resembling
ORCC in ‘knockout’ mice (genotype CFTR(-/-)) disclosed additional evidence that the
two channels were distinct, and that lack of ORCC was not the primary defect in CF
(Gabriel et al., 1993).
Ensuing work has substantiated that ORCC is a distinct chloride channel and a
unique protein, but is regulated by CFTR.

The CFTR protein is required for PKA

activation of ORCC (Egan et al., 1992)(Gabriel et al., 1993)(Jovov et al., 1995).
Expression of recombinant CFTR in CF-affected cell lines results not only in restoration
of chloride channel activity, but also reestablishes PKA activation of ORCC (Egan et al.,
1992) (Gabriel et al., 1993) (Schwiebert et al, 1994). Exactly how CFTR regulation of
ORCC transpires remains unclear.

One model postulates that PKA-phosphorylated

CFTR conducts ATP out of the cell.

On the extracellular surface, ATP acts as an

autocrine stimulator of ORCC through P2u purinergic receptors, which then act through
direct coupling to ORCC or by activation of a G-protein associated cascade (Schwiebert
et al., 1995a).

Interestingly, ATP had no effect on ORCC activity without CFTR

membrane incorporation, or without PKA and ATP presence on the cytosolic side of the
channel (Ismailov et al., 1996). Supporting the role of extracellular ATP in activation of
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ORCC is the adverse effect that ATP scavengers such as hexokinase display on ORCC
chloride current.

In these experiments, hexokinase converted ORCC from a PKA-

sensitive mode to a PKA-insensitive mode, in the continued presence of wild-type CFTR
(Jovov et al., 1995)(Schwiebert et al., 1995a).
Despite these efforts to understand how CFTR may regulate other channels, it is
increasingly clear that cross regulation between channels and cellular proteins is
exceedingly complex.

Current investigations link both cAMP-regulated chloride

channels, ORCC and CFTR, as a complex jointly regulated by a G protein, Gai_2. Data
implies that Gai_2 specifically inhibits ORCC, perhaps in concert with CFTR, creating a
system of negative feedback inhibition of cAMP-activated chloride current. In this study
of a normal human airway epithelial cell line (9HTEo ) expressing both CFTR and
ORCC, stimulation of the G protein with GTP and GTPyS decreased the open probability
(P0) of ORCC, while inhibition of the G protein by GDPBS increased P0.

Addition of

pertussis toxin, which uncouples portions of the heterotrimeric G protein from the
receptor, also increased P0 and restored cAMP-activated chloride current in airway cells
from CF patients (Schwiebert et al., 1995b)(Ismailov et al., 1996). Of note, uncoupling
of the G protein from ORCC altered the rectification characteristics of ORCC and
restored PKA sensitivity in the absence of CFTR, suggesting that both rectification and
PICA sensitivity is influenced by the G protein (Ismailov et al., 1996). Additional results
support the theory that while CFTR chloride channel conductance may be altered by
mediating vesicle trafficking and delivery of chloride channels to the membrane, ORCC
function may receive direct modulation (Schwiebert et al., 1995a).
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1-3.3. Calcium Activated Chloride Channels
The calcium-activated chloride channel demonstrates that epithelial chloride
secretion is regulated by mechanisms involving second messengers other than cAMP. An
increase in intracellular calcium

concentration stimulated transepithelial

chloride

movement in airway epithelia as well as an increase in opening of basolateral potassium
channels (Willumsen and Boucher, 1989). Initial speculation existed as to whether the
calcium-activated pathway stimulated a distinct channel, or whether the different second
messengers each activated the same apical chloride channel.

The possibility that the

pathways culminated in a single final channel was supported by the finding that, like
cAMP-stimulated ion flow, calcium-stimulated chloride conductance is also defective in
cystic fibrosis affected intestine (Anderson and Welsh, 1991).

However, subsequent

studies indicated that in both CF affected and normal airway epithelia, addition of
calcium ionophore A23187 or prostaglandin F2a effected an increase in intracellular
calcium which brought about an increase in chloride ion movement, without changing
intracellular cAMP concentration (Hwang et al., 1989)(Anderson and Welsh, 1991).
Likewise, cAMP- but not Ca2+'regulated chloride conductance is defective in the CFaffected mouse oviduct (Leung et ah, 1995). In contrast, colonic cells lines (T84, Caco-2,
HT-29cl9a) have shown the absence of apical calcium-activated chloride current.

The

presence of chloride conductance in response to an increase in intracellular calcium in
intestinal cells is most likely due to calcium activation of basolateral potassium channels.
The resulting hyperpolarization increases the driving force for chloride movement across
the apical membrane (Anderson et ah, 1992).
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Multiple lines of evidence support the conclusion that the Ca2-dependent and
cAMP-dependent pathways

operate

finally on

distinct

chloride

channels.

The

observation that intestinal cells appear to have a second messenger-activated apical
chloride channel responsive to cAMP but not to calcium suggested that the two pathways
were distinct. Stronger distinction is drawn by examining the biophysical characteristics
between the two channels. Ca2+-activated channels are characterized in T84 colonic tumor
cells by having a linear I-V relation and time-dependent relaxations of chloride current at
both depolarizing and hyperpolarizing voltages (Cliff and Frizzell, 1990).

Anion

permselectivity has the sequence iodide>bromide>chloride (Cliff and Frizzell, 1990).
Addition of D1DS to the basolateral aspect of cultured cells blocks Ca2 '-activated chloride
current, but has no effect on CFTR chloride channels (Anderson and Welsh, 1991).
Notably, an increase in both cAMP and Ca2+ results in an additive increase in chloride
secretion from the apical membrane (Anderson and Welsh, 1991). The combination of
this data indicates that the Ca2+-dependent pathway may modulate chloride secretion
through a different channel than the cAMP-dependent pathway.

1-4. Inflammatory Mediators
1-4.1. Products of Araehidonic Acid
Arachidonic acid is released from cell membranes in response to inflammatory
stimuli and is metabolized to a variety of substances involved in the inflammatory
process,

including

thromboxanes,

the

products

and prostacyclin)

of cyclooxygenase

metabolism

(prostaglandins,

and the products of lipooxygenase metabolism

(leukotrienes), collectively referred to as eicosanoids.

These substances are intricately
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involved in the pathogenesis and promulgation of a broad spectrum of inflammatory
disorders, extending from diseases of the respiratory tract, such as asthma and cystic
fibrosis, to rheumatic diseases, such as arthritis and psoriasis, to resolution of myocardial
infarction (Holtzman, 1991 )(Sigal, 1991).
Arachidonic acid is a 20-carbon fatty acid that is a component of the phospholipid
moiety of cell membranes. When a cell is stimulated phospholipases release arachidonic
acid, which enters one of several metabolic cascades.

The mechanism by which

phospholipases are activated to release arachidonic acid is thought to involve G proteins
linked to a calcium dependent second messenger system (Sigal, 1991).

After release

from the cell membrane, arachidonic acid is oxidized by either cyclooxygenase or
lipoxygenase.

Each of these enzymes catalyzes stereospecific insertion of one or two

molecules of oxygen into arachidonic acid.

1-4.1.1. The Cyclooxygenase Pathway

If the cyclooxygenase pathway predominates, products include prostaglandin
(PG) D2, PGE2, PGF2a, thromboxane A.2, and prostacyclin. The enzyme catalyzes the
attachment of molecular oxygen at the eleventh carbon of arachidonic acid, with
subsequent rearrangement to a cyclic endoperoxide with bridging of carbons 9 and 11.
Introduction by cyclooxygenase of a second molecule of oxygen yields PGG2, while a
hydroperoxidase function of cyclooxygenase performed on PGG2 produces PGH2.
Nonsteroidal anti-inflammatory drugs, in particular aspirin via acetylation, inhibit the
cyclooxgenase activity but not the hydroperoxidase activity of the enzyme.

Additional
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product-specific enzymes convert PGH2 to PGD2, PGE2, and PGF2a (Sigal, 1991). The
subscript in each prostaglandin denotes the two double bonds in the final structure.

In

platelets, the predominant product of arachidonic acid metabolism is thromboxane A2
which is formed from PGH2. Prostacyclin is also formed from PGH2, but is produced by
vascular epithelial cells.
The biologic actions of the products of cyclooxygenase activity are diverse.
Thromboxane

A2,

produced

in

platelets,

has

strong

vasoconstricting,

bronchoconstricting, and platelet aggregating effects. In contrast, prostacyclin, produced
by vascular endothelial cells and both vascular and non-vascular smooth muscle cells, is a
potent inhibitor of platelet aggregation and a vasodilator.

Prostaglandin D2 is the

principal prostaglandin formed by mast cells upon antigen stimulation through binding to
IgE receptors (Roberts et al., 1979)(Lewis et al., 1982); it acts like histamine, causing
strong bronchoconstriction (Sigal, 1991). In addition, PGD isomerase is found in high
concentrations in the central nervous system,
neuromodulatory effects.
platelet

cAMP

suggesting that PGD2

may have

Prostaglandin D2 also inhibits platelet aggregation, inreases

concentration,

and

causes

peripheral

vasodilation,

pulmonary

vasoconstriction, bronchoconstriction, and airway hyperreactivity (Holtzman, 1991).
Like PGD2, PGF2a has vasoconstricting and bronchoconstricting effects, but is produced
by

airway

epithelial

cells.

In

contrast,

PGE2

has

distinct

vasodilatory

and

bronchodilatory actions in human tracheal epithelium. This occurs by a direct effect on
smooth muscle and by an inhibitory effect on acetylcholine release.

Both PGE2 and
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PGF2a are present in response to inflammatory stimuli and increase chloride secretion in
human airway epithelial cells (Eling et al.,

1986)

(Widdicombe et al.,

1989).

Prostaglandin E2 has been shown to inhibit gastric acid secretion and is cytoprotective,
enabling the healing of ulcers and preventing further formation.

1-4.1.2. The Lipoxygenase Pathway
Lipoxygenases are a group of iron-containing dioxygenases that catalyze insertion
of one molecule of oxygen into fatty acids with a l,4-cis,cis-pentadiene structure after
initial stereospecific removal of a hydrogen atom (Holtzman, 1991). Lipoxygenases are
characterized as 5-, 12-, or 15-lipoxygenase to describe the point of oxygen insertion.
The

first

product

of

each

enzyme

is

therefore

5S-,

12S-,

or

15S-

hydroperoxyeicosatetraenoic acid (HPETE), each of which can be further metabolized to
leukotrienes, aldehydes, epoxyhydroxy acids, and glutathione adducts (Holtzman, 1991).
Unlike other enzymes in this pathway, 5-lipoxygenase is specifically stimulated
by calcium and has a strict substrate specificity, requiring double bonds at carbons 5, 8,
11, and 14 for optimal leukotriene formation (Holtzman, 1991).

The enzyme 5-

lipoxygenase converts arachidonic acid to 5-HPETE and, subsequently, 5-HPETE to
leukotriene A4 (LTA4). Leukotriene A4 can either be hydrolyzed to LTB4 or converted
to LTC4 by addition of glutathione. Additionally, catalytic removal of glutamic acid by
transpeptidase produces LTD4; removal of a glycine from LTD4 results in LTE4. The
rate-limiting steps in leukotriene biosynthesis reside in LTA hydrolase and LTC synthase
(Holtzman, 1991).
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The 12-lipoxygenase enzyme was the first in this pathway to be described in
humans, initially in platelets and later in leukocytes (Holtzman, 1991). The first product
of this branch of the pathway, 12-HPETE, is rapidly reduced to the alcohol, 12-HETE, in
most cells, and is the primary biologically active product. Both 12-HPETE and 12-HETE
act as specific inflammatory mediators, notably inducing secretion of neutrophil granules
and augmenting IgE-mediated mast cell release (Holtzman, 1991).
Metabolism of 15-HPETE resembles that of 12-HPETE, resulting in production of
15-HETE. Oxygenation and reduction of 15-HPETE or 15-HETE by 5-lipoxygenase
yields dihydroxy- or trihydroxy-acids called lipoxin A or lipoxin B (Holtzman, 1991).
The 15-lipoxygenase pathway appears to predominate in human lung tissue in asthmatics
(Samuelsson et al., 1987).

1-4.2. Neuropeptides
Neuropeptides, including vasoactive intestinal peptide (VIP), Substance P, and the
tachykinins (neurokinin A and neurokinin B), are a diverse group of peptides released
from nerve endings of the autonomic and non-autonomic nervous systems. In addition to
the cholinergic nerves of the parasympathetic system and the adrenergic nerves of the
sympathetic system, nonadrenergic noncholinergic (NANC) nerves are prominent in the
gut and the respiratory system, and exert a broad spectrum of physiological effects
expressed through release of neuropeptides. The influence of neuropeptides on bronchial
and

vascular

degranulation

smooth
render

muscle,
them

ion

intrinsic

movement,

and

mediators

of

leukocyte
the

proliferation

inflammatory

and

response.
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Physiological response to neuropeptides depends upon localization of receptors and upon
second messengers in target cells.
First described in the gut, NANC networks are not responsive to adrenergic or
cholinergic agonists or antagonists (Richardson, 1979)(Bames, 1984)(Bames, 1986).
NANC

nerves

often

have

opposing

actions,

with

vasoconstriction and vasodilation, bronchoconstriction

mechanisms

exhibiting

and bronchodilation;

both
this

suggests that several different neurotransmitters are involved at each the synapse.
Inhibitory NANC (i-NANC) nerves relax airway smooth muscle. In humans, the NANC
system is the only direct bronchodilating effect because there is no sympathetic
innervation of human airways (Barnes et ah, 1991). Neurotransmitters involved in this
bronchodilating property appear to include VIP and nitric oxide in some experimental
models, although in humans the predominant i-NANC transmitter appears to be nitric
oxide

(Barnes

et

ah,

1991).

Excitatory

NANC

(e-NANC)

elements

bronchoconstriction that is not blocked by atropine (Lundberg et ah, 1987).

cause

This non-

parasympathetic bronchoconstriction is thought to be mediated by tachykinins released
retrogradely from sensory nerves (Barnes et ah, 1991).
Contrary to the original conception, the NANC system is not an anatomically
distinct nervous system but, rather, appears to “fine-tune” the effects of the autonomic
nervous system. Neurotransmitter components of the NANC system are released from
autonomic nerves. For example, i-NANC bronchodilation in the human airway may be
mediated by release of VIP and NO from cholinergic nerves.

Vasoconstrictor effects

result from release of neuropeptide Y from adrenergic nerves.

Excitatory NANC
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bronchoconstriction results from release of tachykinins from sensory nerve endings
(Barnes et al., 1991).

1-4.2.1.

Vasoactive Intestinal Peptide

VIP is a 28 amino acid peptide, and is one of the most abundant neuropeptides in
the human lung (Ghatei et al., 1982). VIP has been localized by immunoreactive analysis
(VIP-IR) to airways and pulmonary vessels; it has been found in nerves and ganglia in
the posterior trachea and intrapulmonary bronchi, becoming less prominent as the airways
become smaller (Lundberg et al., 1984)(Uddman and Sundler, 1987).
fibers are found peripherally in the smaller bronchioles.
usually colocalized in parasympathetic ganglia;

Few VIP-ergic

As discussed above, VIP is

however, isolated ganglion cells have

also been demonstrated, which usually perform like cholinergic nerves (Barnes et al.,
1991). The pattern of distribution largely parallels that of parasympathetic nerves, which
is consistent with the colocalization of VIP and acetylcholine (Laitinen et al., 1985).
Consistent with observation of correlated function, VIP-ergic neurons are found within
bronchial and vascular wall smooth muscle and surrounding submucosal and serous
glands (Barnes et al., 1991). Although receptors for VIP have been discovered in airway
epithelium, no VIP-ergic fibers have been (Said, 1991).
Like B-adrenergic agonists, VIP effects proceed through activation of a G protein
and subsequent second messenger cascade mediated specifically by adenylyl cyclase.
Cellular response to binding of VIP at membrane receptors involves activation of
adenylyl cyclase and subsequent increase in intracellular cyclic AMP (cAMP).

This
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knowledge

has

enabled

identification

of

specific

high

affinity

receptors

by

immunocytochemical detection of increases in cAMP (Lazarus et al., 1986). Localization
of VIP receptors has also been mapped using autoradiography (Carstairs and Barnes,
1986).

Results of these investigations demonstrate a high density of VIP binding in

pulmonary vascular smooth muscle, in smooth muscle of large airways, surrounding
submucosal serous and mucous glands (of the ferret), and in the ciliated and basal cells of
canine tracheal epithelium (Lazarus et al., 1986)(Leys et al., 1986).
VIP has also been found in leukocytes, including neutrophils, eosinophils,
mononuclear cells, and pulmonary mast cells (O'Dorisio et al., 1980)(Lygren et al.,
1984)(Aliakbari et al., 1987).

In addition, VIP receptors are present on the surface of

cells that constitute the inflammatory response, including murine and human Tlymphocytes (Ottaway and Greenberg, 1984), MOLT 4b lymphoblasts (Beed et al.,
1983), human blood monocytes (Guerrero et al., 1981), and rat alveolar macrophages.
The role of VIP in relation to inflammatory cells has not been completely elucidated, but
VIP has been shown to inhibit release of histamine from pulmonary mast cells (Undem et
al., 1983) and may have other characteristic inhibitory or stimulatory features that
modulate the inflammatory response in the respiratory tract.
As stated, VIP in vitro is the primary source of relaxation of airway smooth
muscle; adrenergic antagonists do not inhibit this function. The rich innervation of the
respiratory tract with VIP-ergic fibers and the consequent bronchodilating effect observed
with

stimulation

suggests

that

VIP

may

be

bronchoconstricting effect of parasympathetic

an

essential

stimulation

counterforce

(Barnes

et

al.,

to

the

1991).

Bronchodilation is more prominent in large airways than in smaller bronchioles, which is
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consistent with the predominant VIP innervation noted in bronchi compared with the
paucity of VIP-ergic fibers found in bronchioles (Carstairs and Barnes, 1986). Therefore,
functional bronchodilation by VIP may lie more significantly in large airways than in
progressively peripheral airways.
VIP has similar properties in systemic and pulmonary vascular smooth muscle. In
vitro, VIP has potent relaxant effects on pulmonary vessels, independent of endothelial
cells, which suggests that VIP acts directly on vascular smooth muscle rather than
through an intermediate relaxant factor such as nitric oxide (Greenberg et al., 1987). The
substantially greater number of VIP receptors on pulmonary vascular smooth muscle in
comparison to bronchial smooth muscle indicates why VIP is approximately ten-fold
more potent as a vasodilator than as a bronchodilator (Barnes et ah, 1991).

The

consequence of this receptor distribution may be to improve delivery of blood to
constricted airways during bronchoconstrictive episodes such as asthma (Barnes et ah,
1991).
The juxtaposition of VIP-IR nerves with submucosal serous and mucous glands
results in potent mucus secretion. 35S-labeled glycoprotein secretion of mucus in ferret
airway in vitro is significantly greater than mucus secretion stimulated by isoproterenol
(Peatfield et ah, 1983). The mechanism of signal transduction again relies on G-protein
linked increase in cAMP.
In dog tracheal epithelium, VIP has been shown to be a potent stimulator of
chloride ion transport and therefore water secretion (Nathanson et ah, 1983). The effect
of increased chloride transport across the apical membrane of luminal epithelial cells is
an increase in luminal fluid, with implications for effectiveness of mucociliary clearance.
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The presence of significant numbers of VIP receptors in human airway epithelial cells
suggests that VIP may be an important modulator of this clearance system.

1-5. Inflammation in Airway Disease
Evidence suggests that inflammation plays a dominant role in the propagation of
airway disease, particularly in asthma and cystic fibrosis. In each case, although the path
of tissue destruction differs, the inflammatory mediators described above are involved.
Increases in production of mediators result in a concomitant increase in their modulating
effects on bronchoconstriction, immune function, microvascular permeability, mucus
secretion, and airway fluid production.

Although the effects of the leukotrienes,

prostaglandins, neurokinins, and neuropeptides on bronchial and vascular smooth muscle,
submucosal glands, and epithelial cells have been documented, the precise mechanisms
of action of each of these mediators remain unclear.

1-5.1. Asthma
The clinical picture of asthma derives from the pathogical triad of exaggerated
bronchoconstriction, smooth muscle hypertrophy, and inflammation of the small airways.
A variety of exogenous factors have been identified as triggers of acute asthma attacks:
allergens, exercise, cold air, upper respiratory tract infections, environmental pollutants,
and, in some patients, aspirin. A portion of patients will be identified as having allergic
asthma. These cases are associated with a personal or family history of allergic diseases,
and often have increased levels of IgE in the serum.

A large proportion of patients,

however, will present with no family or personal allergy history and will have negative
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skin and serum tests. They are identified as having idiosyncratic asthma (McFadden, Jr.
1994). In either case, a tendency toward hyperreactivity in the tracheobronchial tree is a
commonality, manifest as unstable lung function due, most likely, to inflammatory
mediators. The degree of inflammation apparent in bronchoalveolar washings parallels
the clinical severity of asthma (Barnes, 1991). Pathophysiologic evidence of asthma is a
reduction in the diameter of the airway lumen, brought about by a combination of
bronchoconstriction,

vascular

congestion,

and

thick,

tenacious

mucus

secretions

(McFadden, Jr. 1994). These manifestations are the result of accumulation of mast cells,
an increase in the number of circulating CD4 T lymphocytes, and an infiltration of
eosinophils with an increased propensity to degranulate (Barnes, 1991).
Inflammatory mediators are prominent components of asthma. Although the role
of cyclooxygenase products is unclear,

the

leukotrienes

are

likely contributors.

Leukotrienes are potent bronchoconstrictors and increase microvascular leakage.

LTD4

receptor antagonists, MK571 and K1204 219, have significant inhibitory effects on
exercise or allergen mediated bronchoconstriction (Lewis et al., 1990).
The NANC system in the lungs, of which VIP is a primary neurotransmitter, is the
principal determinant of airway and pulmonary vessel relaxation, and a fundamental
contributor to the secretion of bronchial fluid and mucus. Mast cell trypsin degrades VIP,
and, if released from mast cells in asthmatic patients, could contribute to neurotransmitter
depletion (Barnes, 1991), thus tilting the balance between NANC relaxation and
cholinergic constriction. Data from immunoreactive staining of lung tissue obtained from
patients with and without asthma demonstrated loss of VIP from pulmonary nerve fibers
in those patients with fatal asthma, regardless of the severity of inflammation
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(Ollerenshaw et al., 1989). This study did not answer the question of whether this loss
was a cause or a result of asthma. Nor could the study conclude whether absent VIP was
secondary to loss of nerves containing VIP, decreased production of VIP by nerves, or
increased breakdown of VIP by resident airway enzymes. This data supported a
hypothesis proposed a decade previously that depletion of VIP in asthmatic patients
might be the cause of characteristic bronchial hyperresponsivity and inflammation
(Richardson, 1979)(Matsuzaki et ah, 1980).
Work with lung tissue from asthmatic patients also demonstrated an increase in
the density of Substance P-immunoreactive nerves in asthmatic lungs, indicating that
hypersensitivity could be due to a relative imbalance between the relaxant properties of
VIP and the constrictor properties of Substance P (Ollerenshaw et ah, 1989). Stimulation
of sensory nerves on airway mucosa can increase vascular permeability, leading to
extravasation of plasma proteins into the airway lumen, vasodilation, neutrophil
adherence, mucus secretion, and bronchoconstriction. Vessels in the pulmonary system
are exquisitely sensitive to such neurogenic stimulus.

Moreover, this effect may be

potentiated by infection (McDonald, 1992).
The reduced cross sectional area of the airway lumen in asthma is not due solely
to bronchoconstriction.

Rather, the bronchoconstrictor response is potentiated by the

degree of amplification of luminal fluid, and its composition, during the inflammatory
response of asthma.

Neurogenic inflammation (via leukotrienes, Substance P, and

neurokinin A) is associated with leakage from venules lying beneath the epithelium; the
resultant exudative fluid is rich in protein and inflammatory mediators, which act on the
airway epithelium to permit leakage into the airway lumen (Yager et ah, 1991).

Once
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across the epithelial barrier, fluid fills the interstices between epithelial folds. The fluid
filling these spaces directly reduces luminal cross sectional area. In addition, if surfactant
is not present in these larger airways, the increase in radius of curvature between points of
epithelium may promote airway closure secondary to high surface tension (Yager et al.,
1991). The net sum is the severe increase in airway resistance observed in asthma.
A possible therapeutic role for VIP in asthma was investigated in human
asthmatics even prior to its known role as an anti-inflammatory agent.

In normal

patients, intravenous infusion of VIP had no effect on airway conductance (Palmer et al.,
1986). In contrast, VIP administration resulted in significant bronchodilation, measured
by improved FEV,, and attenuated histamine-induced bronchoconstriction, in seven
atopic asthmatics (Morice et al., 1983).

Results with inhaled aerosolized VIP have

varied: in six atopic patients, inhaled VIP reduced airway reactivity to histamine, but did
not reduce airway resistance independently (Barnes, 1984).

In another experiment

involving patients with severe asthma, inhaled VIP did impart improvement in airway
conductance, but not to the same degree as inhaled B-adrenergic agonists (Said, 1988). It
is possible that the lack of bronchodilatory response seen with inhaled VIP may be
secondary to poor transit of the peptide across the bronchial epithelium (Barrowcliffe et
al., 1986).
Absence of VIP in the lungs of asthmatic patients could be a primary solitary
defect

creating

a

permissive

environment

with

decreased

attenuation

of

bronchoconstriction and increased microvascular permeability, two of the hallmarks of
asthma. In addition, lack of the stimulus of VIP for ion and water transport could deplete
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luminal secretions, thereby rendering airway fluid thick and immobile.

The ultimate

consequence of decreased VIP, whether absolute or relative to other mediators, might be
a precarious imbalance in the forces acting on an asthmatic’s lungs.

1-5.2. Cystic fibrosis
Cystic fibrosis, an autosomal recessive disorder, is the most common lethal
genetic disease of Caucasians.

The CF gene has been localized to the long arm of

chromosome 7; the multitude of mutations at this region are responsible for the variety of
phenotypes characteristic of this disease.

The most common mutation, deletion of a

phenylalanine at position 508 (AF508) which accounts for genotypic makeup of 70% of
CF patients, results in debilitating disease of the exocrine pancreas function and lung if
not aggressively treated.

With the development of pancreatic enzyme replacement

therapy, lung disease has become the primary source of morbidity and mortality,
accounting for 90% of deaths in CF patients (Davis et al., 1996). The clinical features of
CF are dominated by obstruction of the airways by a thick, tenacious mucus, with
superimposed bacterial infection and colonization by Pseudomonas aeruginosa.

Only

about 0.1% of CF patients with lung disease have normal sweat chloride concentration
(Davis et al., 1980). Approximately 85% of patients demonstrate pancreatic insufficiency
as a result of inspissation of pancreatic ducts, with subsequent fibrosis and deterioration
in exocrine function (Collins, 1992)(Sferra and Collins, 1993).

Associated findings

include infertility in males due to congenital bilateral absence of the vas deferens,
meconium ileus, and liver disease. CF is a clinical diagnosis, consisting of sweat chloride
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concentration greater than 60 mEq/ml, chronic pulmonary disease or pancreatic
insufficiency, and/or history of CF in a sibling or first cousin (Quinton, 1986).
In people without CF, the CFTR protein is localized to the apical membranes of epithelial
cells (Denning et al., 1992b). While AF508 is the most common mutation, there are at
least 500 other mutations identified (Tsui, 1992), each producing phenotypes of varying
severity.

Variability in the site of mutation parallels the wide array of phenotypic

manifestations that comprise the clinical spectrum of CF disease. Each of these groups of
mutations provides a different avenue for therapeutic approaches to the disease based on
modulation of the specific defect.

The mechanism by which the genotypic mutation

creates an inadequate protein product falls into one of four distinct categories:
Category 1 Defective Protein Production:

This class of mutations includes those

in which splice site abnormalities, frameshift mutations, or missense mutations produce
premature stop signals (Tsui, 1992).

These proteins are often unstable and, even if

produced, are either degraded by the cell or have no function.

Thus, these mutations

result in little or no functional CFTR protein anywhere in the cell.
Category 2 Defective Protein Processing: In this group of CF mutations, CFTR is

made by the cell, but is inappropriately trafficked.
class.

The AF508 mutation falls into this

In sweat duct glands, antibodies directed at CFTR do not localize to the apical

membrane of cells affected by this mutation (Kartner et al., 1992). Although the reason
for this mislocalization is not established, errors in the secondary structure producing
improperly folded protein seem likely.

The abnormal structure marks the protein for

degradation rather than movement to the plasma membrane. Of note, when CFTRAF508
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is grown at a lower temperature (23-30°C), some of the mutant protein does appear in its
fully glycosylated form in the cell membrane (Denning et al., 1992a). Reports of whether
CFTRAF508 that is properly processed retains its ability to regulate chloride conductance
vary from a form with activity reduced by one third (Denning et al., 1992b) to one with
normal activity (Li et al., 1993).

If CFTRAF508 does represent a potentially normally

functioning chloride channel, than efforts aimed at correcting abnormal trafficking of the
mutant protein or, alternatively, of augmenting conductance of channels that do reach the
membrane, could prove to be of high therapeutic yield.
Class 3 Defective Regulation: A disproportionate number of missense mutations

have been reported in the nucleotide binding domains of CFTR. When mutations occur
that disrupt binding and/or hydrolysis of ATP, cells produce CFTR with an absolute
reduction in function or with a requirement for higher concentrations of ATP to be
effective (Anderson and Welsh, 1992). Mutations have also been noted in the regulatory
domain, but these appear less frequent than in the nucleotide binding domains, perhaps
because there are multiple degenerate phosphorylation sites in the R domain. Any single
phosphorylation site mutation does not cause lack of function (See Section 1-3.1.2.).
Class 4 Defective Conduction: The transmembrane domain is responsible for the

ion specificity of CFTR. Mutations in this domain produce CFTR in which the protein is
properly processed, appears in the apical membrane, and, in fact, does generate cAMPdependent chloride currents. In all three documented mutations of this type macroscopic
current properties resembled those of normal CFTR, but the single channel conductance
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was reduced. The resulting total amount of current was therefore diminished (Sheppard
et al., 1993).
The fundamental disorder of the mutant CF gene is the lack of production or
mislocalization of a normal-functioning CFTR protein, which, as described above,
regulates chloride conductance via PKA-dependent phosphorylation.

Consequent

derangement in chloride ion movement results in an inability to appropriately control
airway intraluminal fluid, with ever-worsening disruption of mucociliary clearance.
Impaired clearance permits prolonged exposure to noxious stimuli.

Although direct

measurements of mucociliary clearance in CF patients have yielded data revealing
retarded, normal, and increased rates of clearance, patients with clinically more severe
pulmonary disease usually have more substantially impaired mucociliary clearance
(Sanchis et al., 1973).
Early investigations revealed a deficiency in VIP innervation of sweat glands in
patients with CF (Heinz-Erian et al., 1985).

Although this data was gathered prior to

identification of CFTR and knowledge of the primary defect in CF, investigators
recognized the increase in transepithelial potential difference in both sweat gland ducts
and respiratory mucosa, and had attributed this to a decrease in epithelial chloride
permeability (Quinton, 1983).

Sweat glands, like respiratory epithelium, are richly

innervated by the autonomic and NANC nervous systems. As discussed above, VIP is
known to increase chloride conductance across canine tracheal epithelium.

It remains

unclear whether VIP increases chloride conductance through stimulation of CFTR
chloride channels, through activation of the ORCC, or by means of the paracellular
pathway. If the absence of VIP innervation of sweat glands reflects a systemic depletion
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of VIP innervation, then lack of normal stimulation of alternative chloride current routes
may represent an additional defect in CF that adds to the basic defect in chloride channel
operation, and, thus, contribute to desiccation of the airways.

If VIP innervation of

airways were intact, then understanding of the mechanism of increased chloride
conductance via VIP might provide an opportunity for luminal fluid modification.
The clinical course between the initial genetic defect and the evolution of
irreversibly damaged lungs is characterized by recurrent suppurative infections instigated
by Pseudomonas colonization. Patients exhibit a profound inflammatory response which
is self-propagating: neutrophil elastase, released in response to Pseudomonas, destroys
key opsonins, such as IgG and C3bi, as well as opsonic receptors on the surface of
macrophages (Davis et al., 1996). Elastase also stimulates neutrophil chemoattractants,
including LTB4 and IL-8, increases mucus secretion, and causes structural airway
damage (Bruce et al., 1985)(Nakamura et al., 1992). Additional data demonstrates that
certain strains of Pseudomonas express phospholipase C, a hemolysin which directly
induces an inflammatory response when injected into mice. The response is mediated by
an increase in inflammatory cells, plasma protein, and the concentration of both
arachidonic acid metabolites (LTB4, LTC4, LTD4, LTE4) and cyclooxygenase products
(PGF2a, TXB2) (Meyers and Berk, 1990).

This data, combined with previous work

showing the presence of antibodies to phospholipase C in 100% of CF patients, may
explain the chronic inflammation present in CF patients (Granstrom et al., 1984). The
constitutive release of cytokines induced by leukocytes and Pseudomonas products was
recently confirmed, although the heightened cytokine levels were not ascribed to the
CFTR protein defect itself (Bedard et al., 1993).
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It has been proposed that the fundamental interference with mucociliary clearance
is the determining factor in the ultimate colonization with Pseudomonas.
consistent

colonization with Pseudomonas

in

CF patients

amidst

However,

variability

in

mucociliary clearance across CF patients draws into question the causality of a reduced
clearance. Moreover, while post-infection involvement of elastase and the clear response
to Pseudomonas products may explain the chronic inflammation observed in these
patients, there remains a gap in understanding why these patients are prone specifically to
pseudomonal

infection.

Some

researches

speculate

Pseudomonas to CF epithelium (Zar et al., 1995).

an

increased

adherence

of

Other research suggests that the

inflammatory response is itself an integral part of CF, and may predate an intensification
of and predispose to infection. Bronchoalveolar lavage fluid from CF infants reveals an
increase in neutrophils and IL-8, without evidence of intercurrent infection (Khan et al.,
1995).

Likewise, lipid mediators — leukotrienes and prostaglandins — have long been

identified in CF sputum, yet treatment with antibiotics does not always decrease
eicosanoid levels in sputum and other respiratory fluid (Zakrzewski et al., 1987).
Recent investigation suggests that airway epithelia secrete a bactericidal substance
into the fluid bathing the apical surface which depends on low NaCl concentration to
function properly. CF patients have a high chloride concentration on affected epithelial
surfaces secondary to loss of CFTR chloride channels. This research demonstrated that
typical CF pathogens were killed when added to normal epithelia. Moreover, when the
NaCl concentration bathing CF epithelia was lowered from its pathologic level,
Pseudomonas was killed (Smith et al., 1996).

The authors suggest therefore that the

abnormality in sodium and chloride transport not merely affects host defenses by
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impairing mucociliary clearance, but more fundamentally alters the host’s primary
chemical defense.

This line of reasoning requires a model in which respiratory

epithelium is a chloride absorbing, rather than a chloride secreting epithelium, which is in
conflict with the larger body of CF research. Of particular concern in evaluation of this
argument is how the luminal concentration of NaCl could become so large (124-249mM),
given that respiratory epithelium is not considered to be a leaky barrier. That is, even in
the absence of postulated absorptive CFTR chloride channels, how could the luminal
chloride concentration become hypertonic to the plasma?
While these various arguments each has appealing qualities, none fully clarifies
how sodium and chloride ion channels work precisely, or how abnormalities in this
function coalesce to create the clinical picture of CF. Nevertheless, all agree that there is
a baseline dysregulation of chloride movement, secondary to mutation of the CFTR
protein. Understanding more about the structure of this protein, the various channels it
may regulate, and means to manipulate the CFTR gene product through pharmacologic
modulation is essential both to resolving these conflicting data and to providing useful
therapies for those afflicted with CF.
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2. Statement of Purpose

The objective of this study was to employ electrophysiological techniques (cellattached and excised inside-out patch clamping) to describe the effects of a specific
inflammatory mediator, vasoactive intestinal peptide (VIP), on chloride conductance in
cultured airway epithelial cells. The following questions were addressed in this study:
1)

Does pretreatment of cultured airway epithelial cells with VIP result in

increased chloride conductance in the cell-attached or excised inside-out patch?
2) Does VIP increase chloride conductance through a transcellular or paracellular
pathway?
3)

Is there a statistically significant difference in VIP-stimulated chloride

conductance in airway epithelial cells from a cystic fibrosis patient (IB3-1 cell line) and
in “complemented” cells (S9 cell line)?
4) Are the functional characteristics of observed channel activity consistent with
previously described apical chloride channel types, specifically, the cystic fibrosis
transmembrane conductance regulator (CFTR) chloride channel or the outwardly
rectifying chloride channel (ORCC)?
5)

What are possible cellular mechanisms of observed increases in chloride

conductance after pretreatment with VIP?
6) What is the potential therapeutic value of VIP in airway disease?

45

3. Methods

3-1. Patch Clamp Technique
3-1.1. Theory and Configurations
Patch clamp technique was initially conceived of to permit isolation and
characterization of currents flowing through single channels in the membrane of cells.
Continued efforts have resulted in refined techniques and equipment that permit
increasingly higher resolution of channels and advanced manipulation of the environment
surrounding the cells to be studied. These improvements have made it possible to study a
wide variety of cell types.
Patch clamp experiments are a specific type of voltage clamp experiment, that is,
one controls the voltage and measures the transmembrane current required to maintain
that voltage. Provided that no other parameters influence physiologic functioning of the
cell, examining cell membranes under conditions in which the voltage is controlled
allows determination of the effect of shifts in voltage and evaluation of the effect of any
specific mediator if the voltage is held constant. The opening and closing, or “gating” of a
channel can be quantified by measuring the time a channel conducts.

Conductance,

measured as change in single channel current for a small change in membrane voltage, is
roughly constant for a given channel type (Corey, 1983). Units are in amperes per volt,
or siemens (S).
Currents are observed and recorded by placing a glass micropipette flush against
the external membrane of the cell to be studied.

The current recorded is the current
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flowing across the membrane encircled by the tip of the micropipette. Because the crosssectional area at the tip of the pipette is so small, the probability that there is only one or
two channels in the patch of membrane being recorded is high.
Patch clamp configurations are designated by the orientation of the membrane in
relation to the micropipette, and this configuration determines whether the applied
voltage is hyperpolarizing or depolarizing (Sherman-Gold, 1993). There are four basic
configurations for clamping:

cell-attached, inside-out, whole cell, and outside-out

(Figure 3). Each has advantages and disadvantages; the type used for a given experiment
is determined by the type of cell and channel being studied.
In cell-attached patches the membrane patch remains attached to the cell, with the
pipette tip connected to the outside surface of the membrane.

In this case, a positive

command voltage (Vcom) causes the transmembrane potential (Vmem) to become more
negative, and thus is hyperpolarizing.

This configuration is least disturbing to the

structure and internal milieu of the cell. While this may be beneficial for obtaining the
most physiologic data, it limits manipulations one may make. The inner membrane faces
the cytoplasm of the cell, which one cannot control. Moreover, to measure the resting
intracellular potential, one must insert a separate voltage-measuring electrode.
An inside-out patch is created when the pipette is retracted from the surface of the
cell suddenly after a seal is achieved; the surface that was originally the inner membrane
is then exposed to the bath solution, while the previously external membrane now faces
the inside of the pipette. Thus the potential on the true inside surface is OmV, the bath
potential.

The transmembrane voltage can be known exactly.

In this case, a positive

command voltage causes the transmembrane potential to become more negative, and thus
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Low resistance seal

Gigaohm seal

CELL ATTACHED

WHOLE CELL
RECORDING

OUTSIDE-OUT
PATCH

INSIDE-OUT
PATCH

Figure 3. Four patch clamp configurations. This is a schematic illustration of four
different patch clamp configurations and the manipulations that lead to them. Please see
text for details. Adapted from Hamill, et ah, 1981.
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is hyperpolarizing. A key advantage to the inside-out patch is the unlimited access one
has to the cytoplasmic surface of the membrane: during the course of an experiment one
may change the concentration of any mediator or ionic consituent without disrupting the
integrity of the membrane.

The primary disadvantage to this configuration is that the

patch has a propensity to seal over and form a vesicle, which obstructs access to the inner
surface of the membrane and can alter current flow. The risk of vesicle formation can be
minimized by using a bath solution with micromolar calcium concentration, which can be
achieved by the addition of chelators such as EGTA (Corey, 1983).

If a vesicle does

form, it can sometimes be broken by briefly withdrawing the pipette from solution.
Inside-out patch clamping was the sole configuration employed in these experiments.
In a whole-cell patch, the membrane remains attached to the cell, but a brief pulse
of suction results in rupture of the membrane just inside the rim of the pipette.

This

configuration is similar to impaling a cell with a microelectrode, but produces good
recordings on very small cells (Sakmann and Neher, 1984).

In whole-cell patches, the

average activity of all channels in the patch is measured, rather than that of individual
channels.

Thus, this method is useful when the conductance of a given channel is too

small to be measured as a single event (Corey, 1983).
An outside-out patch is derived from a whole-cell patch by slowly withdrawing
the pipette, thereby pulling a tube of membrane away from the cell until the portion of
membrane pinches off.

The membrane patch is detached from the cell such that the

surface that was the outside of the cell remains exposed to the bath solution, and retains
its original OmV potential. As the inverse of the inside-out configuration, the advantage
lies in being able to alter the ionic, hormonal, or neurotransmitter environment on the
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outer surface of the membrane. Outside-out patches are also less likely to form vesicles
(Corey, 1983).

In an outside-out patch, a positive command voltage causes the

transmembrane potential to become less negative, and, hence, is depolarizing.

3-1.2. Micropipettes
Patch clamp microelectrodes consist of an AgCl-coated Ag wire placed in a
solution-filled glass micropipette, which serves as the reservoir for the conducting
solution and the means of connection to the cell membrane.

Early problems in patch

clamping centered on obtaining and maintaining an adequate seal between the edges of
the pipette and the cell. Adequacy of the seal depends on the resistance obtained. When
high seal resistance is achieved, a greater fraction of the membrane current flows into the
pipette rather than leaking out. If there is not a tight adherence between the membrane
and the glass of the pipette, current can leak into the extracellular solution, which
adversely affects recordings obtained:

1)

current lost through leakage will not be

measured; 2) thermal movement of charges through the conducting solution will result
in increased noise in the recording (Sherman-Gold, 1993). Thus, a high resistance seal is
essential to minimize undetected current and to produce low-noise recordings.

Such a

seal is referred to as a “gigaseal,” and is defined as a sudden increase in seal resistance by
as much as three orders of magnitude (Hamill et al., 1981). When a gigaseal is formed,
noise due to current leakage becomes minimal;

other sources of noise, including that

from electronics and the micropipette glass, become the limiting factors in recording
resolution. The two main criteria for achieving gigaseals are use of filtered solutions in
the bath and the pipette, and use of a fresh pipette for each seal (Hamill et ah, 1981).
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Obtaining gigaseals consistently requires that one use clean, freshly fabricated
glass micropipettes, and that they only be used once. Manufacture of pipettes entails a
three step procedure:

pulling of the pipette, coating of the shaft with a hydrophobic

substance, and heat polishing of the tip (Hamill et ah, 1981). Pipette fabrication
equipment includes a Narishige (Tokyo, Japan) PP83 puller and MF-83 microforge.
Glass capillary tubes that are appropriate for the production of micropipettes have walls
of substantial thickness (0.2-0.3mm), which generates less electrical noise and increases
bluntness at the tip, thereby reducing the possibility of cell penetration during seal
formation (Sherman-Gold, 1993).

Gamer glass micro-hematocrit capillary tubing

(Borosilicate, Kimax KG-33 and Coming 7052), with an inside diameter of 1.05mm and
an outside diameter of 1.5mm, is pulled using a two step process in order to ensure a
suitably blunt tip. In addition to wall thickness, three features of the glass used to fashion
pipettes contribute to the quality of the recordings obtained: the temperature at which the
glass softens, the electrical properties of the glass, and the major chemical constituents of
the glass (Sherman-Gold, 1993).

Glasses that soften at low temperatures produce a

blunter tip than glasses that soften at higher temperatures. Borosilicate capillary tubing
softens at 821°-830°C. The dielectric properties of a particular glass are described by its
“loss factor;” glasses with the lowest loss factor exhibit the lowest noise. Finally, glass
made of components with a tendency to leach into the surrounding solution can
unfavorably alter the currents observed.
To minimize noise resulting from solution creeping up the outer walls of the
pipettes, the shafts of the pulled pipettes are coated with a hydrophobic compound,
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Sylgard (Dow Coming, Belgium). Ideally, pipettes are coated to within 100pm of the tip,
and then cured by passing the tip within a heated metal coil.

However, this procedure

was not performed with the latter half of experiments in this study, and appeared to make
no difference in the data obtained. An optimally blunt tip is obtained by firepolishing the
pipette tip.

3-1.3. Channel Recording and Analysis
Data is acquired using the Axopatch 200 integrating patch clamp and the
Pclamp6\TL-l data acquisition and analysis system. Data are digitalized (Sony PCM-601
ESDI audio processor) and stored on either Sony T120PR or Maxel T120P/I Plus
professional grade VHS videotape. Channel data is viewed on an oscilloscope (Nicolet
300).
Recordings are transferred to computer (Gateway 486 computer) in 20 second
sweeps in digitalized form by either an Axopatch TL-1 or a Digidata 1200 interface.
Digitalized files are analyzed using Pclamp6 software (Axon Instruments, Burlingame,
CA). All recordings are analyzed at a filter frequency of 300 Hz. Pclamp6 software was
used to determine mean channel amplitude for each 20 second sweep. A Marquardt Least
Squares fit was employed to determine mean amplitude.
Mean current for each voltage level was determined by Sigmaplot software. I-V
plots were generated, and linear regression of the resulting plot yielded a line, the slope of
which equals the mean current of all channels observed.
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3-2. Tissue Culture
Three cell lines, each with specifically chosen and constructed properties, were
used in these experiments. The IB3-1 cell line consists of clonal descendants taken from
a cystic fibrosis-affected child, and thus lacks normal functioning CFTR protein. The S-9
cell line is the IB3-1 cell line transfected with wild type CFTR. The FHTE cell line is
obtained from normal fetal human tracheal epithelium.

Each of these cell lines were

obtained from Dr. William Guggino at Johns Hopkins University. Dr. Marie E. Egan is
presently culturing these cell lines at Yale University School of Medicine.
Tissue culture techniques employed consist of growing cells in T75 flasks coated
with

a

mixture

of

distilled

water,

fibronectin

(10pg)/bovine

serum

albumin

(BSA)(100pg)/collagen (6mg/ml) and maintained in a 5% C02/95% air incubator at
37°C.

Growth media, LHC-8 supplemented with penicillin (100pg/ml), streptomycin

(lOOpg /ml), tobramycin (80pg/ml), 5% fetal calf serum, and endothelial cell growth
factor (25pg/ml), is changed three times a week. Prior to patch clamp studies, cells are
passaged onto glass chips coated with fibronectin, BSA, and collagen as described above.
They are maintained as described above, and are studied optimally 2 days after passage.

3-2.1. IB3-1 Cell Line
The IB3-1 cell line was created to permit detailed investigation of the specific
genetic defect known to lie behind the lethal disease cystic fibrosis. Zeitlin, et al., used
bronchial epithelium from a patient with CF to establish this immortalized cell line
(Zeitlin et al., 1991). They infected cells with AD-12-SV40, a hybrid of adenovirus 12
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(AD-12) and simian virus 40 (SV40), which had been used successfully in previous
efforts to transform human epithelial cells (Rhim et al., 1985). These earlier studies with
AD-12-SV40 had shown that the virus induces mRNA from the transforming region of
SV40 during transformation. Moreover, it has been shown not to be tumorigenic.
Bronchial epithelial cells were gathered from the airways of a 7-year-old white
male child determined to have CF by sweat chloride test and the presence of severe
obstructive
aeruginosa.

pulmonary

disease

accompanied

by

colonization

with

Pseudomonas

The primary cells (CFBE) were maintained in a mixture consisting of

medium supplemented with endothelial cell growth supplement and antibiotics.

The

CFBE cells were infected with an AD-12-SV40 hybrid after the primary culture reached
80% confluence.

Within 4 to 6 weeks, clusters of clonal growth were apparent.

At

passage 12, CFBE cells were diluted and plated, and, after screening and selection of only
those cells that were non-producers of virus, the clone IB3-1 was cloned a second time.
Radioimmunoassay quantitation of cAMP, genetic analysis, and patch clamp
analysis studies were performed to determine the characteristics of the final IB3-1 clone.
Five criteria were used to judge suitability of this cell line as representative of CF
epithelia:
1. The cells must consistently demonstrate abnormal chloride permeability in the
apical membrane and failure of stimulation of chloride conductance by B-adrenergic
agonists;
2. B-agonist stimulation should increase intracellular cAMP;
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3. the secretory chloride channel should open with depolarizing voltages, but not
in response to phosphorylating agents (e.g. PKA);
4. the DNA must contain the mutant CF gene;
5.

long-term propagation of cells in culture must be possible without loss of

phenotype.
The final IB3-1 clone satisfied all of these requirements. Of note, the patient from
whom the CFBE were harvested was not homozygous for the most common CF
mutation, AF508. These cells are genotypically AF508/W1282X at the CFTR locus. The
W1282X mutation creates a premature stop codon, producing an unstable message and no
CFTR protein. Thus, unlike previous cell lines which only conveyed information about
epithelial cell characteristics in the presence of homozygous mutations, this cell line
provides

information

regarding

the

effects

of alternate

mutations

on

chloride

conductance.

3-2.2. S9 Cell Line
The S9 cell line is the IB3-1 cell line transfected with the wild-type CFTR gene.
With this configuration, data obtained from similar experiments on the two cell lines
permits correlation of the effect of experimental manipulations on the S9 cells
specifically with the presence of a normal functioning CFTR-associated chloride channel.
By creating the “normal” cell line from the defective one, the presence of confounding
differences in other aspects of cell function is eliminated.

55

Flotte, et al., used an adeno-associated vims (AAV) vector to transfect the full
length CFTR cDNA, and demonstrated restoration of cAMP regulation of chloride
conduction ascribed to proper CFTR functioning (Flotte et al., 1993).

AAV vectors

consisting of a p5 transcription promoter and the AAV inverted terminal repeat (ITR)
were used in the development of the IB3-1 line. However, the packaging parameters of
foreign DNA limit its use when the material to be transfected is a large gene, such as
CFTR.

Flotte et al., recognized that the AAV ITR was able to function directly as a

transcription promoter. CFTR cDNA with an amino-terminal deletion, expressed via an
AAV ITR promoter, effectively complemented the CF defect in the IB3-1 cell line.
Cells were tested for functional expression of CFTR by examining the response to
forskolin via chloride efflux assays.

To correlate the appearance of cAMP-associated

increases in chloride conductance with expression of CFTR protein, cells were stained
with anti-CFTR antibodies and examined via immunofluorescence. Results demonstrated
that only cells treated with AAV vectors expressing functional CFTR protein stained
significantly in the immunofluorescence assay. Finally, Southern blot analysis confirmed
the presence of replicating forms of AAV-CFTR vector DNA in all cells treated with
vectors.

3-2.3. FHTE Cell Line
The FHTE cell line was created by Gruenert, et.al., as an object for detailed
studies of the mechanisms of normal epithelial chloride ion transport (Gruenert et al.,
1988). Cells were isolated from human fetal trachea. A plasmid consisting of the simian
virus 40 (SV40) genome which was defective in the origin of replication (pSVori-) was
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chosen

because

this

deficiency

had

previously

been

demonstrated

to

enhance

transformation in human fibroblasts. Although transformed cells experience a change in
phenotype, epithelial cells retain important aspects of the original phenotype after
transformation crisis, including responsiveness to neural agonists (e.g., B-adrenergic
agonists), keratin production, and chloride ion transport.
The residual phenotypic characteristics of these cells were used to assess success
in obtaining an immortalized cell line suitable for experimentation. All cell lines tested
expressed immunoreactivity to keratin in both pre- and post-crisis stages.

Cells were

exposed to the B-adrenergic agonist, isoproterenol, to determine whether the cells
retained the second messenger cascade involving cAMP.

Stimulation with 10'5M

isoproterenol led to an accumulation of cAMP.
Of note, although the respiratory epithelium is a primary site of cystic fibrosis,
studies have demonstrated that CF lung is normal in utero, even when disease is present
in the intestine, vas deferens, pancreas, and liver (Sturgess and Imrie, 1982).

This

suggests that the fetal tracheal chloride channel may operate under different regulation
than the adult respiratory epithelial chloride channel. The lack of disease in the fetal lung
is surprising, given the plethora of CFTR activity present before birth (McCray, Jr. et al.,
1992). If the fetal lung does have alternative chloride channel stimulation mechanisms,
then the FHTE cell line may not be optimal for study of CFTR properties.
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3-3. Protocol
Patch clamp experiments were performed using cell-attached and excised insideout membrane patches from normal (FHTE), CF-affected (IB3-1) and CFTR-transfected
(S9) cell lines. All experiments were conducted at 25-30°C. Bath solution was changed
between each experiment with a 5mL flush. Of 25 experiments included in this report
regarding the effect of VIP, each represents data obtained from the cell-attached and
excised membrane of a distinct epithelial cell.
All cells are pretreated with lpM VIP for ten minutes prior to seal formation.
Cells are visualized with a Nikon Diaphot phase contrast microscope which is mounted
on a Newport anti-vibration airtable to minimize turbulence.

A fresh clean flint glass

micropipette

means

for

each

patch

attempt

is

positioned

by

of a

Newport

micromanipulator. A cell attached configuration is achieved by gently pressing the patch
electrode against the cell membrane of the intact cell. Application of negative pressure
generated by withdrawal of a lOmL syringe provokes development of a high resistance
seal.

After gigaseal formation, patches are observed in the cell-attached position.

Membrane potential is varied using Pclamp software (Axon Instruments, Burlingame,
CA) in lOmV steps from +80mV to -80mV, beginning at +40mV and moving
sequentially outward toward +80mV. Patches are then excised by retracting the pipette
briskly from the cell to obtain inside-out patches. Membrane potential is again varied in
a stepwise fashion.
During recording of excised patches, each patch is observed for rundown in
channel activity representative of depletion of ATP from the bath solution. If rundown is
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noted, exchange of pure bath solution with bath solution containing ATP (ImM) is
attempted with maintenance of the seal.

Solutions and Chemicals

Bath Solution: 150mM NaCl, 2mMMgCl2, ImM EGTA, 5mM Hepes, 0.5 mM CaCl,
Pipette Solution: 150mM NaCl, 2mM CaCl2, 5mM Hepes
The pH of each solution was adjusted to 7.3 with Tris base. All solutions were
filtered at the time of use with a Millipore 0.22 filter.
Synthetic porcine VIP was suspended in standard bath solution to make a stock
solution (ImM). The stock solution was frozen until the day of use. A lpM solution was
made by adding 40pl of stock solution to 40mL of standard bath solution.

VIP was

obtained from Sigma Chemical Co. (St. Louis, MO), product number V3628.
The magnesium salt of ATP was dissolved in standard bath solution to a final
concentration of ImM. The pH of the solution was adjusted to 7.4. ATP solution was
kept on ice between experiments;

remaining ATP solution was frozen for up to one

week. ATP was obtained from Sigma Chemical Co. (St. Louis, MO), product number A9183.
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4. Results

4-1. FHTE Cell Line
Although initial experiments were conducted with the FHTE cell line, difficulties
with maintaining the cells and with patching them prompted continuation of the study
with the IB3-1 and S9 cell lines. FHTE cells did not consistently reach confluence in a
specified time period and were prone to contamination. Cells that appeared amenable to
experimentation proved to be fragile and did not seal reliably.

Preliminary data from

experiments conducted with FHTE is similar to data presented here for S9 cells.
However, the tracings were brief and problematic to analyze due to electrical noise.
Thus, FHTE data is not documented in this report. All of the analyzed data is derived
from experiments involving the IB3-1 and S9 cell lines.

4-2. IB3-1 Cell Line
A gigaseal was successfully obtained and held in thirteen patches of IB3-1 cells.
Each of these cells had been pretreated with lpM VIP solution for ten minutes prior to
seal formation. Patches were first observed in the cell-attached mode. Voltage potential
was initially held at ±40 mV, with recording of the corresponding oscilloscope image
made at lOmV increments up to ±80 mV. After channel activity, or the lack thereof, had
been documented at each level, the patch was excised, and again exposed to holding
potentials ranging from ±40 mV to ±80 mV. Of the thirteen patches in which a gigaseal
was attained and recordings made in the cell-attached mode, eleven were excised with
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maintenance of a non-leaky seal.

Patches in which electrical noise or a poor seal

interfered substantially with possible interpretation of oscilloscope deflections were
terminated prior to completion of the protocol (Table 2).

4-2.1. Presence of ORCC-Like Channel in IB3-1 Cell Line
Nine of the thirteen patches (69%) were silent patches, demonstrating no channel
activity detectable grossly or by analysis with the Pclamp6 program.

Although very

small channels may have been present, activity was not sufficient to be resolvable by the
methods employed.

However, the remaining four patches did demonstrate a large

outwardly rectifying chloride current. Importantly, this channel was only apparent after
the patch had initially been exposed to a depolarizing voltage of at least +70mV. Visual
inspection of the amplitude of the channels present in these four (31%) remaining patches
suggests that these channels are not CFTR chloride channels. The amplitude, mechanism
of activation, behavior after excision, and response to addition of ATP suggests that
deflections observed in these active patches represent ORCC events (Figure 4).
Channels present in these four patches had a large amplitude consistent with the
reported conductance of 20-30pS for ORCC channels. Moreover, the requirement of a
depolarizing voltage of at least +70 mV to activate the channel in each of the four patches
also supports the identification of this large channel as ORCC.

Of note, this channel

remained active at lower voltages after the initial large depolarizing voltage (Figure 5).
In addition, unlike CFTR channel activity which reliably decreases after excision due to a
requirement for a renewable supply of ATP to maintain channel activity, none of the four
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Table 2
Summary of Data Involving IB3-1 Cell Line

Totals
Number of patches

13

Number of patches without chloride channel activity

9

Number of patches with chloride channel activity

4

Percent of patches with any channel activity

31%

Number of patches with other channel activity

4

Number of patches pretreated with VIP

13

Number of patches pretreated with VIP demonstrating
chloride channel activity

4

|

Of Patches Demonstrating Chloride Channel Activity (n=4)
Channel activity observed in cell-attached mode

3

Channel activity observed in excised mode

3

Rundown evident after patch excision

0

Number of patches treated with ATP

3
0

Number of patches treated with ATP demonstrating change
in channel activity
Number of patches demonstrating possible ORCC

4

Percent of patches demonstrating possible ORCC

31%

!

Note: Previous studies of IB3-1 cells conducted in the absence of VIP demonstrate
activation of ORCC only with large depolarizing voltages.
No chloride
conductance was apparent after manipulation of PKA-regulated mechanisms
(Personal communication with Marie E. Egan, M.D.)(Egan, et al., 1992)(Egan, et
ah, 1995).
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Cell-attached at Vcom=-60mV, after pretreatment with lpM VIP for 10 minutes

****

4W

Excised at Vcom=-60mV

>

1 minute after ImM ATP addition, Vcom=-60rnV

Vcom=-60mV, after activation by Vcom=+80rnV

2pA
100ms

Figure 4. Chloride channels in CF airway epithelial cells (IB3-1). Cells from the
IB3-1 cell line were pretreated with lpM VIP for 10 minutes prior to seal formation. The
failure of VIP activation of chloride channels in this patch was monitored for 5 minutes in
both the cell attached and excised modes. Addition of ImM ATP to the cytoplasmic
aspect of the membrane after excision failed to elicit chloride channel activity. Outwardly
rectifying chloride channels were observed after activation by depolarizing voltage. Vcom
is holding potential. Vmem equals -Vcom. Upward deflection represents chloride channel
opening. Arrows indicate the closed state. Data were digitized at 1kHz and filtered for
display at 500Hz. Please note scale where 8mm=2pA.
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Vcom=+40mV, after pretreatment with lpM VIP and excision

VCOm=+40mV, after activation by +80mV

2pA
100ms

Figure 5: Outwardly rectifying chloride channel at low voltage in CF airway
epithelial cells (IB3-1). Cells from the IB3-1 cell line were pretreated with IpM VIP for
10 minutes prior to seal formation. Although no channels were apparent in either the
cell-attached or excised modes initially, activation by depolarizing voltage elicited
outwardly rectifying chloride channel activity. This channel remained active at voltages
of +40 mV or less. Vcom is holding potential. Vmem equals -Vcom. Downward deflection
represents chloride channel opening. Arrows indicate the closed state. Data were
digitized at 1kHz and filtered for display at 500Hz. Please note scale where 16mm=2pA.
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patches with evident channels in the IB3-1 cell line demonstrated “rundown” after
channel excision.
Application of ImM ATP to the solution bathing patches (n=3) that demonstrated
no channel activity did not effect any change in apical current.

This tactic is often

successful in “reviving” CFTR channel activity in patches that have rundown after
excision. However, as demonstrated in Figure 4, addition of ATP to the bath solution of
the IB3-1 cell line brought about no perceptible difference in activity level compared with
prestimulation levels.

4-2.2. Presence of Nonspecific Cation Channel in IB3-1 Cell Line
In four of thirteen patches (31%) a rare small conductance channel was observed
which appeared to be consistent with a nonspecific cation channel (Figure 6). Within this
cell type, as well as in other epithelial cell lines, a nonspecific cation channel ranging
from 10-20pS has been reported previously, as has a smaller cation conductance (5-1 OpS)
activated by stretch. It is unlikely that this channel represents a CFTR chloride channel,
given its generally lower mean conductance, and the apparent lack of ATP or PKA
dependence. However, because ionic substitution experiments were not performed, the
precise nature of this observed channel remains uncertain.

4-3. S9 Cell Line
A gigaseal was successfully obtained and held in twelve patches of the S9 cell
line, which was created by transfecting the IB3-1 line with wild-type CFTR.

Each of
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Excised at Vcom=+50mV

2pA
100ms

Figure 6: Presence of low conductance channel in CF airway epithelial cells (IB3-1).
Cells from the IB3-1 cell line were pretreated with lpM VIP for 10 minutes prior to seal
formation. Rare channel openings were observed in the excised mode in four patches.
Vcom is holding potential. Vmem equals -Vcom. Downward deflection represents channel
opening. Arrows indicate the closed state. Data were digitized at 1kHz and filtered for
display at 300Hz. Please note scale where 16mm=2pA.
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these cells had been pretreated with lpM VIP solution for ten minutes prior to seal
formation. In contrast to the IB3-1 cells, ten of these twelve patches (83%) demonstrated
channel activity and two were silent patches. Like patches from the IB3-1 line, patches
underwent examination throughout the spectrum of holding potentials in both the cellattached and excised modes.

All of the ten patches demonstrated activity in both the

cell-attached and excised modes (Table 3).

4-3.1. Presence of CFTR-Like Channel in S9 Cell Line
Unlike the IB3-1 cell line, patches from S9 cells revealed channels with functional
characteristics representative of CFTR chloride channels. The mean conductance of the
channels observed in these ten samples, calculated from the slope of the linear regression
obtained from plotting mean current versus potential (Figure 7), is 10.4pS±0.39pS, which
is consistent with the expected conductance reported for CFTR of 8-10pS.

Also, as

predicted for CFTR, channel activity ran down after patch excision in eight patches
(80%) initially displaying oscilloscope deflections (Figure 8).

In the two remaining

active patches in which rundown was not documented, the seal broke after channel
activity similar to that present in the other eight patches was observed, but before
rundown occurred. It is likely that these channels also would have exhibited a decrease in
activity had the seal of the patch remained stable.
Moreover, in the patches exhibiting rundown after excision, 75% (3/4) of patches
treated with ImM ATP demonstrated a burst of channel activity within three minutes of
addition of ATP, which is consistent with CFTR chloride channels (Figure 8).
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Table 3
Summary of Data Involving S9 Cell Line

Totals
Number of patches

12

Number of blank patches

2

Percent of patches with channel activity

83%

Number of patches pretreated with VIP

12

Number of patches pretreated with VIP demonstrating
channel activity

10

Of Patches Demonstrating Chloride Channel Activity (n=10)
Channel activity observed in cell-attached mode

8

Channel activity observed in excised mode

10

Rundown evident after patch excision

8

Number of patches treated with ATP after rundown

4

Number of patches treated with ATP demonstrating
restoration of channel activity

3

Number of patches demonstrating possible ORCC

5

Percent of patches demonstrating possible ORCC

50%

Note: Previous studies of S9 cells conducted in the absence of VIP demonstrate
that CFTR chloride channel activity is seen only when cells are stimulated with
agents that increase cAMP (forskolin, IBMX) or when excised patches are exposed
to PKA and ATP. ORCC is activated either by PKA and ATP addition or by large
depolarizing voltages (Personal communication with Marie E. Egan, M.D.)(Egan, et
al., 1992)(Egan, etal., 1995).
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Figure 7. I-V relationship of low conductance channels in S9 cells pretreated with
VIP. This figure demonstrates the I-V relationship for low conductance channels in
excised inside-out patches bathed in symmetrical chloride solutions [01],= [Cl']0 =
150mM (n=10). Patches were excised from S9 cells pretreated with lpM VIP. The I-V
relationship was linear over the voltage range studied. The mean conductance was
10.4pS ±0.39pS. The solid line represents a linear regression fit to the data.
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Excised at Vcom=+70mV, after pretreatment with lpM VIP

5 minutes after excision, Vcom=+70mV

1 minute after ImM ATP addition, Vcom=+70rnV

2pA
100ms

Figure 8: Activation of low conductance chloride channel in “complemented” IB3-1
cells (S9). Cells were pretreated with lpM VIP for 10 minutes prior to seal formation.
Initially, low conductance channel activity is observed. Rundown of low conductance
chloride channel occurred within 5 minutes of patch excision. Addition of ImM ATP to
the cytoplasmic surface of the patch resulted in restoration of low conductance channel
activity. Vcom is holding potential. Vmem equals -Vcom. Downward deflection represents
chloride channel opening. Arrows indicate the closed state. Data were digitized at 1kHz
and filtered for display at 500Hz. Please note scale where 8mm=2pA.
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4-3.2. Presence of ORCC-Like Channel in S9 Cell Line
In addition to the smaller, presumed CFTR chloride channel, five of ten (50%)
patches exhibited a larger channel suggestive of ORCC (Figure 9). Moreover, eruption of
activity invariably coincided with instigation of a high depolarizing voltage of at least
+70mV. These channels were not present at voltages less than ±70mV unless the patch
had first been exposed to a depolarizing voltage greater than or equal to +70mV. This
channel did not demonstrate rundown in any of the five patches, and thus, the affect of
added ATP on ORCC activity was not specifically investigated.

However, addition of

ATP (ImM) following rundown of the small conductance channel did not result in a
concurrent increase in ORCC activity.

4-3.3. Patches Without Channels in S9 Cell Line
Two of the total twelve patches were silent. Channel activity was absent in both
the cell attached and excised modes, and did not appear with ATP addition or
depolarization (Figure 10).

It is likely, therefore, that these two patches contained no

channels in the cell membrane sampled.

4-4. Statistical Analysis
Due to the small sample size of patches analyzed for each cell line, the Fischer
exact test was employed to determine the significance of any observed differences
between cell lines in the presence of channels in the apical membranes.

Presence of

CFTR-like chloride currents in the S9 cell line, but not in the IB3-1 cell line produced a P
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value of 0.00002. Presence of ORCC-like chloride currents in both the S9 and IB3-1 cell
lines produced a P value of 0.6882.
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Vcom=+50mV, after activation by V^^+SOmV

—'V/AA^rv-nn/'x/^—uuv*r

2pA
100ms

Figure 9: Outwardly rectifying chloride channel in “complemented” IB3-1 cells
(S9). Cells from the S9 cell line were pretreated with lpM VIP for 10 minutes prior to
seal formation. In addition to the linear low conductance channel (not demonstrated in
this figure), a larger outwardly rectifying channel was observed, which was present only
after activation by depolarizing voltage. VC0]n is holding potential. Vmem equals -Vcom.
Downward deflection represents channel opening. Arrows indicate the closed state. Data
were digitized at 1kHz and filtered for display at 500Hz. Please note scale where
8mm=2pA.

73

Cell-attached at Vcom=+60mV, after pretreatment with lpM VIP for 10 minutes

Excised at Vcom=+60mV

1 minute after ImM ATP addition, Vcom=+60mV

Vcom=+60mV, after activation by Vcom=+80mV

2pA
100ms

Figure 10: Silent patch in “complemented” IB3-1 cells (S9). Cells from the S9 cell
line were pretreated with lpM VIP for 10 minutes prior to seal formation. The failure of
VIP activation of chloride channels in this patch was monitored for 5 minutes in both the
cell-attached and excised modes. Addition of ImM ATP to the cytoplasmic aspect of the
membrane after excision failed to elicit chloride channel activity.
No outwardly
rectifying chloride channels were observed with depolarizing voltage. Vcom is holding
potential. Vmem equals -Vcom. Downward deflection represents channel opening. Arrows
indicate the closed state. Data were digitized at 1kHz and filtered for display at 500Hz.
Please note scale where 8mm=2pA.
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5. Discussion

5-1. Effect of VIP on Chloride Conductance in Airway Epithelial Cells
This study set out to define the mechanism by which VIP increases chloride
conductance in airway epithelial cells. We postulated that VIP could act via three unique
mechanisms:

indirect stimulation through initiation of a second messenger cascade;

direct action on chloride channels; or loosening of tight junctions and increase of current
through a paracellular path (Figure 11).
A likely pathway included activation of CFTR chloride channels.

However,

although VIP is known to increase cAMP intracellularly and research has demonstrated
CFTR to be a cAMP-dependent chloride channel, one cannot assume that VIP therefore
activates CFTR chloride channels through cAMP.

As outlined in this paper, several

apical chloride channels exist in epithelial cells, at least two of which — CFTR chloride
channels and ORCC — are cAMP-dependent and regulated by CFTR. Characterization of
the chloride current is a first necessary step in pinpointing the mechanism of VIP current
activation. A second crucial component in attributing the observed increase to CFTR is
to demonstrate that an identical current is not observed upon stimulation with VIP in cells
that do not contain the CFTR chloride channel.

This study provides evidence that the

mechanism of VIP augmentation of chloride current relies on activation of CFTR.
However, the data does not unequivocally support or contradict the role of cAMP as the
second

messenger

involved

in

transduction

of the

initiating

chemical

signal.
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Cl

2. VIP

Cl

Cl

4. VIP

1. VIP

Key to Symbols:

VIP receptor

G protein

CFTR

ORCC

Tight junction

Figure 11. Possible Mechanisms of VIP Stimulation of Chloride Secretion in
Airway Epithelia.
1. VIP activates intracellular cascade, which subsequently activates CFTR chloride
channels.
2. VIP acts directly on the extracellular or intracellular aspect to stimulate CFTR
chloride channels.
3. VIP activates ORCC either indirectly through initiation of intracellular cascade and
regulation by CFTR, or directly.
4. VIP acts indirectly through receptors or directly on the epithelial surface to uncouple
tight junctions, thus increasing chloride permeability of the layer.
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5-2. VIP Indirectly Activates CFTR Chloride Channels
Given understanding of the independent mechanisms of VIP and CFTR, one
possible mechanism of increased apical chloride current involves stimulation of CFTR by
an increase in cAMP brought about by VIP.

Presuming the concentration of VIP was

sufficient and that VIP properly activated membrane receptors, all S9 cells pretreated
with VIP experienced an increase in intracellular cAMP.

In 83% of patches examined

from these cells, a 10.4pS±0.39pS current appeared that corresponds in magnitude and
direction of flow to that expected for chloride currents generated uniquely by CFTR.
This channel has no intrinsic activity at baseline; that is, CFTR demonstrates no chloride
current unless it is stimulated by exogenous addition of cAMP or PKA with ATP, or by
another agent that supports endogenous supply of cAMP from adenyl cyclase, such as
forskolin, IBMX, or a B-adrenergic agonist.
increasing cAMP.

Likewise, VIP is an agent capable of

Thus, a possible scheme might involve VIP-induced generation of

cAMP, with consequent phosphorylation of CFTR by PKA and increase in apical
chloride current.
Such a model in which VIP activates CFTR is bolstered by two other findings
significant for CFTR-generated chloride flow in S9 cells. First, the small linear chloride
conductance

observed

in

the

cell-attached

mode,

which

has

conductance

of

10.4pS±0.39pS when excised, ran down to prestimulation levels upon excision in eight of
the ten patches with documented channel activity. In CFTR chloride channels, rundown
after excision occurs in part when the R domain is dephosphorylated by specific
phosphatases near the detached cell membrane and is not rephosphorylated due to the
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absence of PKA in the vicinity of the channel. Channel activity is restored by addition of
the catalytic subunit of PKA and ATP to the bathing solution. A second pertinent finding
is the restoration of the identified 10.4pS±0.39pS current in three of four patches treated
with ATP after rundown. Depletion of ATP in the bathing solution after excision is the
causative factor in channel rundown observed in CFTR channels.

Resurgence of the

previously documented current reflects resupply of nucleotide triphosphate for both
binding and hydrolysis necessary for channel opening.

Other chloride channels

recognized in the apical membrane of airway epithelial cells do not exhibit this
characteristic pattern of rundown and restoration of current with ATP addition.
In addition, the overwhelmingly different response to VIP observed in S9 cells
compared with IB3-1 cells suggests that VIP does activate a pathway whose end-target is
stimulation of CFTR.

While the small conductance channel appeared in 83% of S9

patches pretreated with VIP, none of the thirteen IB3-1 cells pretreated with VIP
manifested a similar channel.

This disparity represents a statistically significant

difference with P=2xl0"5. The only genetic dissimilarity between these two cell lines is
the presence of CFTR in the S9 cells. In fact, the S9 cell line is derived from the IB3-1
cell line: cells obtained from a CF-affected boy (IB3-1 cell line) were transfected with
wild-type CFTR to create the S9 line, the only distinguishing characteristic of which
would be the presence of the CFTR gene product.
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5-3. VIP Directly Activates CFTR Chloride Channels
Another possible pathway is that VIP acts directly on chloride channels without
an intervening second messenger.

While the data on conductance and behavior does

suggest activation of a CFTR chloride channel, the path of activation could be direct
rather than indirect. Although VIP demonstrably increases cAMP in cells, activation of a
second messenger cascade, ostensibly designed to magnify the response in physiologic
systems, may be bypassed in a system in which fine-tuning of the current is desired.
Amplification may not be the goal. Under this rubric, VIP, which is not permeable to the
membrane, would activate the channel by binding directly to it on the extracellular
surface.

Alternatively, VIP could somehow gain access to the cytosolic side of the

channel by movement through an unidentified transporter.
If VIP acts directly on the extracellular surface of the channel, one might expect to
see an initial burst of activity corresponding to association of VIP with the channel.
Provided this connection involved consumption of VIP, one might also see rundown of
channel activity as the supply of VIP was depleted.

While rundown was observed in

patches that demonstrated the VIP-stimulated channel, the pattern of rundown argues
against direct stimulation by VIP. Rundown only occurred in patches after excision, and,
in fact, was correlated with excision. If rundown were secondary to depletion of VIP,
then a decrease in conductance should have been observed in both cell-attached and
excised modes as the supply of VIP in the bath solution was diminished. In vivo, VIP is
rapidly degraded by extracellular and membrane-associated enzymes.

Although these

experimental conditions did not recreate the milieu in which this reaction might
conceivably occur in vivo, it seems unlikely that rundown would occur only and reliably
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with excision. If extracellular stimulation is the mode of action of VIP in human airway
tissue, then one might reasonably expect to see rundown in the cell-attached mode as a
natural component of channel gating. Rundown in the cell-attached mode did not occur
in any of the ten patches with this channel.
If rundown were secondary to depletion of VIP, one would expect to see
restoration of activity with addition of VIP after rundown.
explored in this protocol.

This maneuver was not

However, the restoration of activity with ATP, although not

precluding direct VIP activation, does suggest CFTR is phosphorylated, perhaps through
the proposed cAMP and PKA pathway.
Factors argue strongly against direct activation of VIP on the cytosolic surface of
the channel.
membrane.

First, and perhaps most convincing, is that VIP does not cross the cell
One must postulate an as yet unidentified transporter by which VIP could

gain access to the cytosolic side. Alternatively, if a means of access to the cytosolic side
was lost in the in vitro setting, one might observe channel activity after excision once the
cytosolic facet of the channel was exposed to VIP in the inside-out patch.

In these

samples, however, channels were apparent in both cell-attached and excised modes.
Second, if VIP acted on the cytosolic aspect of the channel, an appreciable delay
as VIP crossed the membrane prior to binding would not be surprising. In all of the S9
patches demonstrating channel activity with VIP stimulation (n=10), that activity was
apparent immediately upon seal formation.

However, one must allow that the time

allotted for pretreatment with VIP may have been sufficient for transport across the
membrane to occur.
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5-4. VIP Increases Chloride Conductance through a Paracellular Pathway
Another possible mode for an increase in chloride flow from the basal to the
apical aspect of epithelial cells is through a paracellular, rather than transcellular, path.
This formulation involves binding of VIP to receptors to stimulate loosening of tight
junctions between epithelial cells.

This is the least likely mechanism of the chloride

conductance observed in these experiments.

If this were the mechanism of action, it

would not be revealed by an increase in current observed in the experimental setup we
employed. Ion flow between cells would not be witnessed during recordings of patches
of membrane from those cells. Thus, even if VIP does have an effect mediated through a
paracellular path, it also has the effect reported here attributable to activation of apical
CFTR chloride channels.

5-5. VIP Activates ORCC
The apical membrane of the epithelial cells studied contains a second potentially
cAMP-regulated channel, the ORCC. Knowing that ORCC can be activated by cAMP,
one can construct a model in which VIP increases chloride conductance through ORCC
by augmentation of intracellular cAMP. If cAMP is the path by which VIP stimulates
chloride flow, then this channel could also serve as the end target of VIP stimulation.
However, ORCC requires the presence of CFTR in the membrane to be cAMPactivated.

If VIP modulates chloride conductance through cAMP, IB3-1 cells should

display fewer activated ORCC than S9 cells due to the lack of CFTR in the IB3-1 cell
line.

Analysis of both cell lines showed that 31% of IB3-1 patches versus 50% of S9
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patches demonstrated ORCC channels.

In contrast to the difference in CFTR chloride

channel activity, there is no difference (P=0.6882) in the appearance of ORCC.
Arguing against cAMP as the mediator of VIP and ORCC as a possible end-target
is the lack of a temporal association between addition of VIP to either S9 or IB3-1 cells
and appearance of channel activity. While the smaller, 10.4pS±0.39pS current appeared
in S9 cells pretreated with VIP immediately upon seal formation, the larger current was
not observed in any patch (S9 or IB3-1) until after initial depolarizing voltages of at least
+70mV.

This is surprising because one would expect to see an increase in PKA-

dependent ORCC activity corresponding to CFTR activity in the S9 cells, without a
requirement for voltage activation.
The sum of the data on ORCC activation in both cell lines does not support a
mechanism in which VIP increases chloride conductance via cAMP activation. In the S9
cell line, PKA regulation of ORCC is normal, and one should therefore see an increase in
ORCC activity above that observed in the IB3-1 cell line if VIP acts through cAMP. One
explanation is that the number of observations obtained in this study is too small to
demonstrate a statistically significant difference in ORCC activation between the two cell
lines. That is, ORCC is in fact activated in the S9 cell line by VIP mediated increase in
cAMP. Because the kinetics of ORCC channels stimulated by the cAMP pathway differ
from those stimulated by voltage activation, kinetic analysis of single channel patches
would provide a means to delineate the mechanism of ORCC activation. Although single
channel data was not obtained in these samples, future studies could examine the kinetics
of the ORCC channels observed in these two cell lines to clarify whether VIP is
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responsible for channel activation.

Alternatively, VIP may act directly on CFTR as

outlined above, or it may elicit activation of CFTR via cAMP in a manner which
uncouples CFTR regulation of ORCC.

5-6. Therapeutic Implications of VIP Activation of an Apical Chloride Channel
In cystic fibrosis severity of disease directly correlates with the amount of
chloride ion effectively secreted across the apical membrane of various epithelia.

In

people with CF in whom VIP innervation may be abnormal, discovering ways to increase
putative VIP-induced chloride channels would clearly have little value.

However, in

patients in whom VIP innervation is intact, increased chloride current mediated through
VIP stimulation could present an attractive therapeutic option that utilizes physiologic
pathways to treat this systemic disease, whether VIP acts indirectly through a cAMPdependent mechanism or directly on CFTR chloride channels.
The data in this study strongly suggest that VIP increases apical chloride
conductance in airway epithelial cells by stimulating CFTR chloride channels. Whether
VIP acts on CFTR directly, or through increases in intracellular cAMP, remains
unresolved. If, in fact, VIP is a member of the family of protein agonists that stimulate
CFTR by increasing cAMP (i.e., methylxanthines, IBMX), then VIP is potentially useful
in the multitude of CF mutations in which CFTR is made but does not function optimally.
These categories of mutations create phenotypes characterized by an absolute insufficient
amount of CFTR, protein that spends a disproportionate amount of time in the closed
state, or protein that is improperly trafficked to the membrane.

The most common CF
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mutation, AF508, produces a protein without proper trafficking signals. Only a fraction
of the necessary CFTR arrives to function at the plasma membrane.

Similarly, in

treatment of CF patients with adenovirus vector transfection of wild-type CFTR,
maintenance of a surfeit of chloride channels in the apical membrane is often a
therapeutic problem. Targeting agonists that increase cAMP would maximize stimulation
of CFTR present in the plasma membrane, ensuring that chloride secretion, even in a cell
with reduced numbers of chloride channels, proceeds most efficiently.
If, as the data on ORCC activation in this study suggest, VIP stimulates CFTR
chloride channels through a mechanism that does not involve cAMP as a second
messenger, then the value of VIP in CF may be even greater. By utilizing VIP as a
potential CFTR agonist in conjunction with known cAMP agonists, therapies could be
designed to fully maximize CFTR stimulation. In patients with CF mutations like those
described above, using VIP to augment PKA-regulated chloride channel activity would
provide a two-pronged approach to increasing ion movement necessary for airway
function.
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